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INTRODUCTION 
 
 Wounds  
A wound can be described as a defect or a break in the skin, resulting from physical or 
thermal damage or as a result of the presence of an underlying medical or physiological 
condition
1
. According to the Wound Healing Society, a wound is the result of ‘disruption of 
normal anatomic structure and function with consecutive loss of function’2.  
Of all the body tissues, the skin is definitely the most exposed to damage and easily prone 
to injury, abrasions and burns due to trauma or surgery. The rapid restoration of homeostatic 
physiological condition is a prerequisite for a complete lesions repair, because a slow and 
incorrect repair can cause a series of damage including the loss of skin, hair and glands, the 
onset of infection, the occurrance of skin diseases, a injury to the circulatory system and, in 
severe cases, death of the tissue
3
. To prevent these undesirable effects it is essential that the 
body activates a series of fine regulated mechanisms for a quick and efficient wounds repair in 
order to reduce the possibility of irreversible damage to the skin structure. For all these reasons, 
wound repair is one of the main biological processes in humans. 
Given the complexity of the wound repair process, it is remarkable that it rarely becomes 
uncontrolled and that malignant transformation is an uncommon event in the wound 
environment
4,5
. For most injuries, repair results in once functional tissue becoming a patch of 
cells (mainly fibroblasts) and disorganized extracellular matrix (mainly collagen) that is 
commonly referred to as a scar (Figure 1). Surprisingly, in some eukaryotic organisms, the 
response to injury can completely recapitulate the original tissue architecture through a process 
of regeneration. Humans have this ability during prenatal development, but this is lost during 
adult life
6
. How regeneration occurs and why humans lose this ability remain a mystery
7
. 
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Figure 1. Macroscopic wound healing of hand abrasion. A: 0 Day; B: 2 Days; C: 17 Days; D: 30 Days. 
Source Wikipedia (http://en.wikipedia.org/wiki/Abrasion_%28medical%29). 
 
 
The closure of a skin wound can be realized by regeneration or repair. While regeneration 
describes the specific substitution of the tissue, i.e. the superficial epidermis, mucosa or fetal 
skin, skin repair displays an unspecific form of healing in which the wound heals by fibrosis and 
scar formation. The latter, unfortunately, represents the main process in adult skin wound 
healing. The knowledge gained through studies carried out on cells that can regenerate itself, 
might help to unlock latent regenerative pathways in humans and to transform a fibrotic healing 
process in a regenerative one, restoring the original tissue functions. This will greatly improve 
the quality of life and it would change medical practice, as happened with the introduction of 
antibiotics in the twentieth century
8
.  
In general, the wound repair process occurs in almost all tissues after exposure to almost 
any destructive stimulus. Integumental injuries are defined as open or outer wounds, whereas 
inner or closed wounds describe injuries or ruptures of inner organs and tissues with a still intact 
skin. Thus, the sequence of events that follows a myocardial infarction (heart attack), for 
example, is remarkably similar to that following a spinal-cord injury, a burn or a gunshot 
wound, despite the different types of insult and the different organs affected. Likewise, scar 
formation that occurs during wound repair leads to similar tissue dysfunction wherever it takes 
place. In the case of myocardial infarction, the formation of myocardial scar tissue is thought to 
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result in congestive heart failure (a condition in which the heart cannot supply the body’s tissues 
with enough blood) and/or abnormal heart rhythms (arrhythmias), which together account for 
nearly 100,000 deaths each year in the United States alone
9
. In addition, cirrhosis of the liver 
and some forms of fibrosis of the lungs are thought to result from fibrotic responses to toxin-
mediated injury
10
. Interestingly, in other circumstances, the liver is one of the few organs in the 
human body that can regenerate up to 70% of itself without scar formation. Why the liver’s 
regenerative capacity manifests only in some cases remains incompletely understood. A leading 
hypothesis is that the immune system is involved in the switch between regeneration and 
fibrotic healing, because human fetuses, which heal without scarring, have immature immune 
systems
11
.  
 
Based on the nature of the repair process, wounds can be classified as acute or chronic 
wounds. Acute wounds are usually tissue injuries that heal completely, with minimal scarring, 
within the expected time frame, usually 8–12 weeks12. The primary causes of acute wounds 
include mechanical injuries due to external factors, such as abrasions, which are caused by 
frictional contact between the skin and hard surfaces. Mechanical injuries also include 
penetrating wounds caused by knives and gun shots and surgical wounds caused by incisions, 
for example to remove tumors. Another category of acute wounds include burns and chemical 
injuries, which arise from a variety of sources such as radiation, electricity, corrosive chemicals 
and thermal sources. The temperature of the source and the exposure time influence the degree 
of a thermal burn
13
. Chronic wounds on the other hand arise from tissue injuries that heal 
slowly, that have not healed in 12 weeks
14
 and often reoccur. Such wounds fail to heal due to 
repeated tissue insults or underlying physiological conditions
15
 such as diabetes and 
malignancies, persistent infections, poor primary treatment and other patient related factors. 
These result in a disruption of the orderly sequence of events during the wound healing process 
(see later). Chronic wounds include decubitus ulcers (bedsores or pressure sores) and leg ulcers 
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(venous, ischemic or of traumatic origin). Wounds are also classified based on the number of 
skin layers and area of skin affected
16
.  
Injury that affects the epidermal skin surface alone is referred to as a superficial wound, 
whilst injury involving both the epidermis and the deeper dermal layers, including blood 
vessels, sweat glands and hair follicles is referred to as partial thickness wound. Full thickness 
wounds occur when the underlying subcutaneous fat or deeper tissues are damaged in addition 
to the epidermis and dermal layers. Ferreira et al.
17
 have described both acute and chronic 
wounds that are difficult to heal as ‘complex wounds’ with unique characteristics. The 
properties of complex wounds can be summarized as: (a) extensive loss of the integument 
which comprises skin, hair, and associated glands; (b) infection (e.g. Fournier’s gangrene) 
which may result in tissue loss; (c) tissue death or signs of circulation impairment; (d) presence 
of underlying pathology.  
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1.1. Wound healing 
Wound healing is a specific biological process related to the general phenomenon of 
growth and tissue regeneration. The process of wound healing can artificially be divided into 
three to five phases which overlap in time and space 
18
 
 
 
 
Figure 2. Evolution in time of physiological stages of wound repair 
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Figure 3. Classical stages of wound repair. There are three classical stages of wound repair: inflammation 
(a), new tissue formation (b) and remodelling (c). Inflammation (a) lasts until about 48 h after injury. 
Depicted is a skin wound at about 24–48 h after injury. The wound is characterized by a hypoxic 
(ischaemic) environment in which a fibrin clot has formed. Bacteria, neutrophils and platelets are 
abundant in the wound. Normal skin appendages (such as hair follicles and sweat duct glands) are still 
present in the skin outside the wound, New tissue formation (b) occurs about 2–10 days after injury. 
Depicted is a skin wound at about 5–10 days after injury. An eschar (scab) has formed on the surface of 
the wound. Most cells from the previous stage of repair have migrated from the wound, and new blood 
vessels now populate the area. The migration of epithelial cells can be observed under the eschar. 
Remodelling (c) lasts for a year or longer. Depicted is a skin wound about 1–12 months after repair. 
Disorganized collagen has been laid down by fibroblasts that have migrated into the wound. The wound 
has contracted near its surface, and the widest portion is now the deepest. The re-epithelialized wound is 
slightly higher than the surrounding surface, and the healed region does not contain normal skin 
appendages. Adapted from Gurtner G.C. et al.
19
. 
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1.1.1. The Vascular Response: Hemostasis and Coagulation 
The first stage of physiological or acute wound healing is dedicated to hemostasis and the 
formation of a provisional wound matrix, which occurs immediately after injury and is 
completed after some hours (fig. 1). Furthermore, this phase initiates the inflammatory process. 
Sometimes this phase is also described as the ‘lag-phase’, in which the organism has to manage 
the recruitment of many cells and factors for the healing process in the absence of the 
mechanical strength of the wound.
20
 The different clotting cascades are then initiated by clotting 
factors from the injured skin (extrinsic system), and thrombocytes get activated for aggregation 
by exposed collagen (intrinsic system). At the same time the injured vessels follow a 5- to 10-
min vasoconstriction, triggered by the platelets, to reduce blood loss and fill the tissue gap with 
a blood clot comprising cytokines and growth factors
21
. Furthermore, the blood clot contains 
fibrin molecules, fibronectin, vitronectin and thrombospondins, forming the provisional matrix 
as a scaffold structure for the migration of leukocytes, keratinocytes, fibroblasts and endothelial 
cells and as a reservoir of growth factors. The life-saving vasoconstriction with clot formation 
accounts for a local perfusion failure with a consecutive lack of oxygen, increased glycolysis 
and pH-changes
22
. The vasoconstriction is then followed by a vasodilation in which 
thrombocytes invade the provisional wound matrix. In addition, platelets and leukocytes 
influence the infiltration of leukocytes by the release of chemotactic factors
23
.  
 
1.1.2. The Cellular Response: Inflammation 
The inflammatory phase of the wound healing cascade gets activated during the 
hemostasis and coagulation phase and can roughly be divided into an early phase with 
neutrophil recruitment and a late phase with the appearance and transformation of monocytes 
(figure 4). The inflammatory response to injury is essential for supplying growth factor and 
cytokine signals that are responsible for cell and tissue movements and considered crucial for 
the subsequent repair mechanisms in adult mammalians
24
. Due to the response of the activated 
complement pathway, degranulated platelets and by-products of bacterial degradation, 
neutrophils are recruited to the site of the skin injury and are present for 2–5 days unless the 
wound gets infected. The work of the neutrophils is crucial within the first days after injury 
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because their ability in phagocytosis and protease secretion kills local bacteria and helps to 
degrade necrotic tissue. Furthermore, they act as chemoattractants for other cells that are 
involved in the inflammatory phase
23
. Approximately 3 days after injury, macrophages enter the 
zone of injury and support the ongoing process by performing phagocytosis of pathogens and 
cell debris
25,26 
as well as secretion of growth factors, chemokines and cytokines (figure 4). 
Macrophages have many functions including host defense, the promotion and resolution of 
inflammation, the removal of apoptotic cells and the support of cell proliferation and tissue 
restoration following injury
27
. 
 
 
Figure 4. Cutaneous wound healing three days after the injury 
 
 
1.1.3. Proliferation and Repair 
In the phase of proliferation (approx. 3–10 days after injury) the main focus of the healing 
process lies in covering the wound surface, in the formation of granulation tissue and in 
restoring the vascular network. Therefore, next to the migration of local fibroblasts along the 
fibrin network and the beginning of reepithelization process from the wound edges, 
neovascularization and angiogenesis get activated by capillary sprouting.
28
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The last step in the proliferation phase is the development of the acute granulation tissue 
(figure 5 ). At the same time the remodeling phase is already initiated. The granulation tissue is 
characterized by a high density of fibroblasts, granulocytes, macrophages, capillaries and 
loosely organized collagen bundles (figure 5). Since the angiogenesis is not completed yet, this 
tissue is highly vascularized and for this reason it appears with a classic redness and might be 
easily traumatized. However, the dominating cell type in this phase is the fibroblast, which 
fulfils different functions such as the production of collagen and ECM substances (i.e. 
fibronectin, glycosaminoglycans, proteoglycans and hyaluronic acid). Subsequently, the 
synthesis of collagen increases throughout the wound, while the proliferation of fibroblasts 
declines successively, adjusting the balance between synthesis and degradation of the ECM
29
. 
 
 
Figure 5. Cutaneous wound healing five days after the injury 
 
 
1.1.4. Remodeling 
Remodeling is the last phase of wound healing and occurs from day 21 to up to 1 year 
after injury. The formation of granulation tissue stops through apoptosis of the cells. A mature 
wound is, therefore, characterized as avascular as well as acellular
30
. During the maturation of 
the wound the components of the ECM undergo certain changes. Collagen III, which was 
produced in the proliferative phase, is now replaced by the stronger collagen I. This type of 
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collagen is oriented in small parallel bundles and is, therefore, different from the basket-weave 
collagen in healthy dermis
31
. Later on, myofibroblasts cause wound contractions by their 
multiple attachment to collagen and help to decrease the surface of the developing 
scar
25,
Errore. Il segnalibro non è definito.
31
. Furthermore, the angiogenic processes diminish, 
the wound blood flow declines, and the acute wound metabolic activity slows down and finally 
stops. The epidermis of the resultant scar differs from uninjured skin after wound healing due to 
the lack of rete pegs that are normally anchored into the underlying connective tissue matrix and 
are responsible for the tight connection of the epidermis to the dermis 
 
 
1.1.5. Molecular mechanisms of wound repair 
Following the observation that genes regulated in response to skin injury are functionally 
important for the wound repair process, DNA-microarray showed that the gene-expression 
pattern of healing skin wounds strongly resembles that of highly malignant tumors
32
, 
highlighting the importance of functional genomics studies for research into wound repair and 
cancer. The proteins involved in re-epithelialization have been described by Raja et al.
33
 and 
include various extracellular-matrix proteins and their receptors, proteases (including matrix 
metalloproteinases), cytoskeletal proteins, and enzymes that regulate the cellular redox balance 
(Table x). 
 
Table 1. Soluble mediators of re-epithelialization. Adapted from Gunter et al. Nature 2008. 
 
Ligand  Receptor Type of receptor Signaling proteins Role in re-epithelialization 
HGF  MET 
Receptor tyrosine 
kinase 
Unknown, possibly ERK1 and 
ERK2, AKT, GAB1, PAK1 
and/or PAK2 
Stimulation of keratinocyte 
migration and probably 
proliferation 
FGF7, FGF10 
and FGF22 
FGFR2-IIIb, possibly 
FGFR1-IIIb 
Receptor tyrosine 
kinase 
Unknown, possibly ERK1, 
ERK2, AKTand/or STAT3 
Stimulation of keratinocyte 
proliferation and migration 
Heparin-binding 
EGF and other 
EGFfamily 
members 
EGFR (also known as 
ERBB1), possibly 
ERBB2, ERBB3 and/or 
ERBB4 
Receptor tyrosine 
kinase 
Unknown, possibly ERK1 and 
ERK2, AKT and/or STAT3 
Stimulation of keratinocyte 
proliferation and migration 
TGF-β  
TGF-β receptor I and 
TGF-β receptor II 
Receptor 
serine/threonine 
SMAD3 and others, including 
SMAD2 and MAPK 
Inhibition of keratinocyte 
proliferation and survival 
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kinase 
Acetylcholine  
M3 receptor 
G-protein-coupled 
receptor 
Ca2+-dependent guanylyl 
cyclase, cyclic  GMP and PKG, 
leading to inhibition of RHO 
Inhibition of keratinocyte 
migration 
M4 receptor 
G-protein-coupled 
receptor 
Adenylyl cyclase, cyclic AMP 
and PKA, leading to activation 
of RHO 
Stimulation of keratinocyte 
migration 
Catecholamines, 
Including 
adrenaline 
β2-Adrenoceptor  
G-protein-coupled 
receptor 
Activation of phosphatase 
PP2A, resulting in 
dephosphorylation and 
inhibition of ERK1 and ERK2 
Inhibition of keratinocyte 
migration 
Polyunsaturated 
fatty acids 
PPAR-α and PPAR-β* Nuclear receptor 
Direct activation of target 
genes by binding to the 
promoter/enhancer of these 
genes 
Stimulation of keratinocyte 
migration and survival 
EGF, epidermal growth factor; EGFR, EGF receptor; ERK, extracellular-signal-regulated kinase; FGF, fibroblast growth factor; FGFR1-IIIb, IIIb isoform of FGF receptor 1; 
GAB1, growth-factor-receptor-bound protein 2 (GRB2)-associated binding protein 1; HGF, hepatocyte growth factor; M3, muscarinic receptor subtype 3; PAK, p21-activated 
kinase; PKA, cyclic-AMP-dependent protein kinase; PKG, cyclic-GMP-dependent protein kinase; PPAR, peroxisome-proliferator-activated receptor; SMAD3, SMAD-family 
member 3; STAT3, signal transducer and activator of transcription 3; TGF-β, transforming growth factor-β. *PPAR-β ligands might be fatty acids. 
 
 
1.2. Wound Exudate 
Thomas
34
 has described wound exudate as: ‘a generic term given to liquid produced from 
chronic wounds, fistulae or other more acute injuries once hemostasis has been achieved’. It is 
essentially formed by blood from which most of the red cells and platelets have been removed. 
Exudate is a key component in all the stages of wound healing, irrigating the wound 
continuously and keeping it moist.
35
 The maintenance of a moist wound bed is widely accepted 
as the most ideal environment for effective wound healing.
36
 Exudate also supplies the wound 
with nutrients and provides favorable conditions for migration and mitosis of epithelial cells
37
 
and leucocytes, which helps to control bacteria and reduce the incidence of infection at the 
wound surface. 
 
 
1.2.1. Composition of exudate 
Exudate contains a variety of substances including water, electrolytes, nutrients, 
inflammatory mediators, white cells, protein-digesting enzymes (e.g. matrix metalloproteinases 
– MMPs), growth factors and waste products. Exudate is derived from the fluid that has leaked 
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out of blood vessels and closely resembles blood plasma. Fluid leaks from capillaries into body 
tissues at a rate that is determined by the leakiness (permeability) of the capillaries and the 
pressures (hydrostatic and osmotic) across the capillary walls. The relationship between the 
factors that determine how much fluid leaks out is known as Starling’s hypothesis. In general, 
most (about 90%) of the leaked fluid is reabsorbed into capillaries, but small amount that is not 
reabsorbed (about 10%) is returned to the central circulation via the lymphatic system. As a 
result, in the steady state, leakage from capillaries is balanced by the reabsorption and drainage 
of fluid. In a wound, the initial injury initiates inflammation, an early stage of the healing 
process. Mediators involved in inflammation, e.g. histamine, increase capillary permeability so 
that white blood cells can escape and the blood vessels leak more fluid. The excess fluid enters 
the wound where it forms the basis of exudate (Figure 6). 
 
 
Figure 6. exudate homeostasis in wound healing 
 
 
In the healing wound, exudate appears to promote healing in a number of ways, including 
stimulating cell proliferation. MMPs, which break down the cell-supporting extracellular 
matrix, are present mainly in an inactive form. In wounds not healing as expected (chronic 
wounds), exudate appears to have opposite effects. This exudate contains elevated levels of 
inflammatory mediators and activated MMPs. 
 
 
1.2.2. Exudate management 
Nowadays the wound exudate is generally recognized as a key factor in wound healing. 
Although a moist environment is necessary for optimal wound healing, conditions of extreme 
wetness or dryness may adversely affect healing. In a healing wound, exudate production 
generally reduces over time, but in certain conditions, such as chronic wounds, there is 
14 
 
 
excessive amounts of exudates which can lead to complications. In a wound that is not healing 
as expected, exudate production may continue and be excessive due to ongoing inflammatory or 
other processes. 
The amount of exudate produced by a wound is partly dependent on surface area. 
Consequently, the larger the surface area, the greater the likely volume of exudate. Some wound 
types are perceived to have high rates of exudate production, e.g. burns, venous leg ulcers, skin 
donor sites and inflammatory ulcers (rheumatoid and pyoderma gangrenosum). However, these 
are often large wounds and so would be expected to produce higher volumes of exudate
38
  
Traditionally, information about exudate is gained from examination of colour, 
consistency, odor and amount (Figure 7). These characteristics may indicate components, 
contaminants or underlying cause (Tables 2). 
 
 
 
 
Figure 7. A) Mainly clear, serous, thin exudate with granulation tissue visible in the wound bed; B) Thick 
haemopurulent exudate. (Photos copyright of the Cardiff and Vale NHS Trust – Professor Keith Harding) 
 
 
 
 
 
 
Table 2. Colour, consistency and odor of exudate
39
. 
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Significance of exudate color* 
Characteristic Possible cause 
Clear, amber  Serous exudate, often considered ‘normal’, but may be associated with 
infection by fibrinolysin-producing bacteria such as Staphylococcus 
aureus; may also be due to fluid from a urinary or lymphatic fistula 
Cloudy, milky or creamy  May indicate the presence of fibrin strands (fibrinous exudate– a 
response to inflammation) or infection (purulent exudatecontaining 
white blood cells and bacteria) 
Pink or red  Due to the presence of red blood cells and indicating capillary damage 
(sanguineous or haemorrhagic exudate). 
Green  May be indicative of bacterial infection, e.g. Pseudomonas aeruginosa 
Yellow or brown  May be due to the presence of wound slough or material from an 
enteric or urinary fistula. 
Grey or blue  May be related to the use of silver-containing dressings 
Significance of exudate consistency 
High viscosity  
(thick, sometimes 
sticky)  
 
 High protein content due to infection or inflammatory process 
 Necrotic material 
 Enteric fistula 
 Residue from some types of dressings or topical preparations 
Low viscosity  
(thin, ‘runny’) 
 Low protein content due to venous or congestive cardiac disease or 
malnutrition 
 Urinary, lymphatic or joint space fistula 
Significance of exudate odour 
Unpleasant   Bacterial growth or infection  
 Necrotic tissue 
 Sinus/enteric or urinary fistula 
 
In local wound management, dressings are the main option for managing exudate. A key 
characteristic of modern wound dressings is the removal of excess exudate while maintaining 
moisture at the wound bed.
40
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1.3. Factors Which Impair Wound Healing: Chronic Wounds 
Although most wounds will heal uneventfully, problems can sometimes occur, that lead 
to failure of the wound to heal or a prolonged healing time. Failure of a wound to heal within 
the expected time frame usually results in a chronic wound. A chronic wound fails to heal 
because the orderly sequence of events is disrupted at one more of the stages of wound healing 
A chronic wound is defined as a loss of integrity of a skin surface area including one or 
more layers of underlying structures, which fail to heal within eight weeks
41
. Different factors 
can affect a regular wound healing process, such as underlying pathobiology or microorganism 
invasion and when this happen failure to heal occurs often leading to a chronic wound (ulcer). 
Furthermore, impaired wound healing can lead to an excessive production of exudates 
that can cause maceration of healthy skin tissue around the wound
42
  
 
 
 
Figure 8. Tissue injury results in an acute wound healing response under normal physiologic conditions 
but may fail when underlying pathobiology or microbial invasion interfere with the healing process, 
thereby creating a chronic wound. Adapted from Clark et al.
43
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Underlying pathobiology known to interfere with acute wound healing includes venous 
insufficiency that results in fluid transudation and fibrin cuffing of venules secondary to high 
hydrostatic pressure in the venous system; diabetes mellitus that results in high glucose and both 
cell and ECM dysfunction from non-enzymatic glycation; arterial occlusion or high external 
pressure that results in tissue hypoxia and cell dysfunction or death. Bacteria colonizing the 
wound often produce a biofilm composed of a wide variety of polysaccharides. The biofilm 
protects these colonies of mixed microorganisms, as it is relatively impervious to phagocytic 
cells and impermeable to antibiotics. Frustrated phagocytes release a plethora of proteases and 
toxic oxygen radials into the wound milieu making a bad situation worse as these agents destroy 
tissue cells, extracellular matrix, and growth factors in the wound. Not surprisingly, such 
chronic wounds lack epidermal migration and ingrowth of granulation tissue. 
In addition, exudate from chronic wound differs from acute wound fluid with relatively 
higher levels of tissue destructive proteinase enzymes
44
 and therefore more corrosive. The smell 
and staining caused by exudate can also have a negative impact on a patient’s general health and 
quality of life
45
. On the same time underlying diseases such as diabetes
46
 and anemia delay 
wound healing because compromised circulation results in the delivery of inadequate nutrients, 
blood cells and oxygen to the wound (table 3).  
 
Table 3. Crucial factors in the development of chronic wounds and wound healing disorders. 
Confounding factor  Examples  
Circulatory disorders  
PAD, chronic venous insufficiency, lymphedema, right 
ventricular insufficiency 
Metabolic factors  
Diabetes mellitus, renal insufficiency, hepatic disease, tumors, 
cachexia, malnutrition 
Injuries and chronic-degenerative disorders 
of the soft tissue, muscle and skeletal 
systems 
Fractures with mal-alignment, arthrosis, rheumatoid arthritis, 
diabetic neuro-osteoarthro-pathy (Charcot foot) 
Nervous disorders  Polyneuropathy, stroke 
Skin diseases  
Allergies, infectious and immunological skin diseases, 
collagenosis, cancer 
Local factors  Postoperative scars, radiotherapy, foreign matter, hematomas 
Medication  Glucocorticoids, immunosuppressives, cytostatics 
Local noxins  Incontinence, pressure stress, burns 
Toxins Nicotin, drugs, alcohol 
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Other problems associated with wound healing include the formation of keloid scars, 
rubbery lesions resulting from excess collagen production in the latter part of the wound healing 
process
47
. Also foreign bodies introduced deep into the wound at time of injury can cause 
chronic inflammatory responses delaying healing and sometimes leading to granuloma or 
abscess formation.  
Bacterial contamination on the wound site is a negative predictor for wound healing. 
Pathogenic bacteria such as S. aureus, P. aeruginosa, S. pyrogenes and some Proteus, 
Clostridium and Coliform species can be detrimental to the healing process. Inadequate control 
measures to manage infected wounds can lead to cellulitis (cell inflammation) and ultimately 
bacteraemia and septicaemia, both of which can be fatal. It has been shown that the presence of 
P. aeruginosa and S. aureus significantly reduced skin graft healing and also that 94% of ulcers 
that were slow to heal, or recurred after discharge, contained S. aureus
48
.  
Poor nutritional status and old age
49
 also reduce the ability to fight infection. Protein, 
vitamin (e.g. vitamin C) and mineral deficiencies impair the inflammatory phase and collagen 
synthesis, leading to prolonged healing times
50
.  
Treatment with drugs such as steroids suppress the body’s inflammatory responses and 
thereby impede the inflammatory stage of wound healing, which eventually leads to a 
compromised immune response. Glucocorticoids for example have been shown to impair 
wound healing in both rats and humans
51
, due to inhibition of the production of keratinocyte 
growth factor (KGF)
52
. Also some nonsteroidal anti-inflammatory drugs (NSAIDs) (e.g., 
aspirin, ibuprofen) interfere with wound healing by decreasing collagen production. The precise 
mechanism is not fully understood.  
Radiation therapy is an established modality in the treatment of head and neck cancer 
patients. Compromised wound healing in irradiated tissues is a common and challenging clinical 
issue
53
. Radiation damages the ability of the tissues to promote new blood vessel growth as well 
as interferes with cellular functions necessary for wound healing. These effects are not 
reversible once the radiation exposure has been completed and in fact may worsen with time. 
Because of these effects, a seemingly minor injury in an area that previously received radiation 
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may result in a chronic, open wound. Vitamin E has been shown to improve wound strength in 
areas exposed to radiation but often the entire wound may need to be excised to remove the 
damaged, radiated tissue.  
In a long-standing wound that looks clean but still will not heal, the wound may be 
harboring an underlying cancer.
54
 The concern about an underlying cancer is especially 
applicable in chronic wounds in elderly patients and on sun-exposed areas of the body. We tend 
to expect basal cell or squamous cell skin cancers to be relatively small (< 2–3 cm), but, if left 
untreated, they can grow to be quite large. Cancer of the breast and soft tissue sarcomas can 
erode through the skin to create a chronic open wound.
55
 
Common chronic skin and soft tissue wounds include the diabetic foot ulcers, pressure 
ulcers, and the venous stasis ulcers.  
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 WOUNDS DRESSINGS 
A dressing is defined as a piece of material used to cover and protect a wound.
56
 Natural 
skin is considered the perfect wound dressing and therefore an ideal wound dressing should try 
to replicate its properties
57
. Once the cause is identified and properly treated, the basic principle 
of wound treatment is essentially the same for all kind of injuries, that is use of a proper wound 
dressing. Different types of wounds and the different stages of a healing wound require different 
dressings or combinations of dressings. The following table shows suitable dressings for 
particular wound types.  
 
Table 4. suitable dressing for wound types 
 
 Wound type Dressing type 
 
Clean, medium-to-high 
exudate (epithelialising)  
 Paraffin gauze  
 Knitted viscose primary dressing  
 
Clean, dry, low exudate 
(epithelialising)  
 Absorbent perforated plastic 
film-faced dressing  
 Vapour-permeable adhesive film 
dressing  
 
Clean, exudating 
(granulating)  
 Hydrocolloids  
 Foams  
 Alginates  
 
Slough-covered  
 Hydrocolloids  
 Hydrogels  
 
Dry, necrotic  
 Hydrocolloids  
 Hydrogels  
 
Often the dressings may require secondary dressings such as absorbent pad and bandages. 
Several factors apart from the choice of wound dressings need to be considered to ensure 
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successful wound healing. In the case of chronic wounds, underlying factors such as disease, 
drug therapy and patient circumstance must all be taken into account and addressed before a 
particular wound dressing is selected. Table x describes factors to be considered in the choice of 
wound dressings based on their performance characteristics (functions).
1,,58
 
 
Table 5. Functions (Desirable Characteristics) of Wound Dressings according to Eccleston 
59
  
 
Desirable Characteristics Clinical Significance to Wound Healing 
Debridement (wound cleansing)  Enhances migration of leucocytes into the wound bed and supports 
the accumulation of enzymes. Necrotic tissue, foreign bodies and 
particles prolong the inflammatory phase and serve as a medium 
for bacterial growth 
Provide or maintain a moist wound 
environment 
Prevents desiccation and cell death, enhances epidermal migration, 
promotes angiogenesis and connective tissue synthesis and 
supports autolysis by rehydration of desiccated tissue 
Absorption. Removal of blood and excess 
exudate 
In chronic wounds, there is excess exudate containing tissue 
degrading enzymes that block the proliferation and activity of cells 
and break down extracellular matrix materials and growth factors, 
thus delaying wound healing. Excess exudate can also macerate 
surrounding skin 
Gaseous exchange (water vapour and air) Permeability to water vapour controls the management of exudate. 
Low tissue oxygen levels stimulate angiogenesis. Raised tissue 
oxygen stimulates epithelialisation and fibroblasts 
Prevent infection: Protect the wound from 
bacterial invasion 
Infection prolongs the inflammatory phase and delays collagen 
synthesis, inhibits epidermal migration and induces additional 
tissue damage. Infected wounds can give an unpleasant odour 
Provision of thermal insulation Normal tissue temperature improves the blood flow to the wound 
bed and enhances epidermal migration 
Low adherence. Protects the wound from 
trauma 
Adherent dressings may be painful and difficult to remove and 
cause further tissue damage 
Cost effective Low frequency of dressing 
change 
Dressing comparisons based on treatment costs rather than unit or 
pack costs should be made (cost-benefit-ratio). Although many 
dressings are more expensive than traditional materials, the more 
rapid response to treatment may save considerably on total cost 
 
Due to the distinct characteristics of the different types of wounds and of each of the 
wound healing stages, there is no one single dressing that can be efficiently applied in all 
situations. However, it is possible to develop and to optimize different biocompatible wound 
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dressing materials in terms of their chemical and physical properties, e.g. moisture absorption 
and permeation capacities, in order to meet most of the needs for a particular wound stage.
60
 
 
2.1. History of dressings 
The history of wound care spans from prehistory to modern medicine. The aim of wound 
treatment has always been to reduce the risks caused by the wound itself and to minimize 
potential complications. The first written records containing medical information on clay tablets 
discovered in Mesopotamia and dated around 2500 B.C.. Over the centuries, such systems have 
become more sophisticated, but their primary goal of healing damage remains the same. 
In early civilization, medicine was a mixture of magic and empiricism and was practiced 
by wizards.
61
 Wound treatment was no more scientific in Egypt, despite the great anatomic 
knowledge resulting from the Egyptians' intricate embalming technique. The most of Egyptian 
medicine is derived from other civilization, in fact the first medical papyri from Egypt, the 
Smith papyrus (about 1650 B.C.), is considered to be a copy of a much older document.
62
 The 
agents most used in Egypt were probably mixtures of honey and lard or honey and resin. The 
grease-soaked gauze in Egyptian times
63
 can be considerate the first attempt to advanced 
dressing. Furthermore the Egyptians appear to have learned that a closed wound heals faster 
than an open one. They invented the adhesive bandage by applying gum to linen strips and 
using these to draw wound edges together. Severe bleeding may have been treated with cautery. 
Greek medicine borrowed much from the older Egyptian, especially after the two cultures 
met in Alexandria from about 300 B.C., but a medical tradition had existed in Greece since the 
time of Asklepios, approximately five hundred years earlier. Hippocrates (460-377 B.C.) is 
widely considered to be the "Father of Medicine" and was the first to believe that diseases were 
caused naturally, not because of superstition and gods. He suggested that contused wounds 
should be treated with salves in order to promote suppuration, remove necrotic material and 
reduce inflammation. He preferred leaving wounds dry once they had been washed and he 
recommended the use of wine or vinegar for washing. Honey and oil as well as wine were 
among the most widely used ointments, though wool boiled in water or wine was considered a 
useful dressing. 
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The Romans had no medical tradition and no physicians until Greeks settled in Rome 
about 200 B.C.. One of the most important encyclopedic opera about the medical knowledge at 
that time was the “De Medicina” written by Aulus (perhaps Albinovarus) Cornelius Celsus (ca 
25 B.C. - ca 50 A.C.). Celsus wrote clearly on the care of wounds and was the first to define the 
four cardinal signs of inflammation (though not when discussing wounds): 'Notae vera 
inflammationis sunt quattuor; rubor et tumor cum calore et dolore'. He described a variety of 
different wounds and gave detailed descriptions of their treatment, classifying topical 
preparations according to their effects on the wound. After Celsus this knowledge was 
reconsidered and improved by Claudius Galeno (c.129-200 A.C.). Although Galen was a skilled 
surgeon (he had served four years as a surgeon to the gladiators in Pergamon) , he relied heavily 
on medicines and advocated polypharmacy. He waited a large number of treatises, which were 
so accurate that even his hypotheses were universally accepted as fact and remained 
unchallenged until the Renaissance. 
 
Table 6. natural remedies used in Roman and Greek medicine 
 
Animal  Vegetable  Mineral  
Bile  Bark Alum  
Blood  Dyes Antimony 
Butter  Fruit Arsenic 
Cobweb  Herbs Clay 
Cochineal  Honey Copper salts 
Egg-white  Leaves Lead salts 
Faeces  Oils Mercury salts 
Lard or grease  Resins Potassium salts 
Meat  Sap Tar or pitch  
Milk  Sugar Zinc salts 
 Turpentine  
 Wine or vinegar  
 
 
During the Middle Ages, following the teaching of Greek and Roman medicine, wounds 
were left to “rot a bit” in order to develop “laudable pus,” which meant the patient would 
24 
 
 
actually survive.
64
 During this age the surgeon believed that the pus was a decisive element of 
healing and tried in every way to provoke its formation, by introducing foreign bodies and 
liquids irritating the wound. On the contrary, in the Renaissance prevailed the orientation to 
keep the wound clean at all costs, draining the moods, removing the necrotic and above all make 
sure that no foreign objects remain within. 
Around 1500 the introduction of gunpowder into Europe started a violent controversy 
over the way in which gunshot wounds should be treated. In the seventeenth century the 
classical procedure in case of gunshot injury consisted in a surgical exploration to eliminate the 
foreign bodies penetrated into the tissues using surgical tools or substances that were believed to 
have this ability. After appropriate explorations, the wound was filled with tow or linen wedges 
and medicated with different balms. The gunshot wound treatment was the same until the First 
World War when the chemist Henry Drysdale Dakin invented the Dakin's solution, made of 
sodium hypochlorite and boric acid, to wash out the traumatic wounds of British soldiers 
fighting in France. During World War II, large scale production and the diffusion of penicillin 
made a major difference in the number of deaths and amputations caused by infected wounds 
among allied forces, saving an estimated 12%–15% of lives. 
The first advances in wound care in modern era began with the work of Ignaz Philipp 
Semmelweis, a Hungarian obstetrician who discovered how hand washing and cleanliness in 
medical procedures prevents maternal deaths. Semmelweis's work was furthered by an English 
surgeon, Joseph Lister, who in 1860s began treating his surgical gauze with carbolic acid, 
known today as phenol, and subsequently dropped his surgical team's mortality rate by 45%. A 
number of new discoveries have been made throughout the years, but the real revolution in 
wound care occurred in 1962 when George D. Winter published his work on surface induced 
acute lesions on domestic pigs.
65
 By covering a lesion with a film of occlusive material 
(polyethylene), Winter obtained a moist environment that ensured a more rapid re-
epithelialization as compared to the healing of the lesion left to dry in air. This study, which was 
lacking in some aspects (non-standardized animal model, tests only on acute and not chronic 
wounds), has paved the way to a new way of managing wounds: the moist wound healing. Until 
then, in fact, a dry lesions was considered crucial, especially to counteract bacterial colonization 
and subsequent infection. Hence, the concept of advanced dressing emerged as opposed to the 
traditional ones. Traditional dressings were designed to cover and hide the wound by absorbing 
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excess exudate, while with Winter’s work the concept of interaction between medication and 
ulcerative lesion began, with the ultimate goal of creating an environment suitable for the 
acceleration of the tissue repair process. 
In the 1990s, improvements in composite and hybrid polymers expanded the range of 
materials available for wound dressing. Grafting and biotechnology have produced useful 
protective covering of actual human skin generated through cloning procedures. These 
improvements, coupled with the developments in tissue engineering, have given rise to a 
number of new classes of biological wound dressings. Among these the "Living skin 
equivalents" are very promising and may have the potential to serve as cellular platforms for the 
release of growth factors essential for proper wound healing. 
 
 
2.2. Classification of dressings 
Dressings are classified in a number of ways depending on their function in the wound 
(debridement, antibacterial, occlusive, absorbent, adherence), type of material employed to 
produce the dressing (e.g. hydrocolloid, alginate, collagen) and the physical form of the dressing 
(ointment, film, foam, gel).
66
 Dressings are further classified into primary, secondary and island 
dressings. Dressings which make physical contact with the wound surface are referred to as 
primary dressings while secondary dressings cover the primary dressing. Island dressings 
possess a central absorbent region that is surrounded by an adhesive portion. Other 
classification criteria include traditional dressings, modern and advanced dressings, skin 
replacement products and wound healing devices. Classification criteria can be useful in the 
selection of a given dressing but many dressings fit all the criteria.
1
 In this thesis dressings are 
classified as traditional or modern (moist wound environment) dressings. 
 
 
2.2.1. Traditional wound dressings  
These were used commonly in the past and though now less widely used, they are still of 
some benefit in certain clinical settings for wound treatment. Traditional wound healing agents 
include topical liquid and semi-solid formulations as well as dry traditional dressings. 
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Topical formulations can be liquid (solutions, suspensions and emulsions) or semi-solid 
(ointments and creams) and their use is widespread. Solutions, such as povidone-iodine, are 
useful in the first stage of wound healing as antimicrobial agents, but they have short residence 
times on the wound site, especially where there is a measurable degree of suppuration (exuding) 
of wound fluid. Semi-solid preparations such as silver sulphadiazine cream and silver nitrate 
ointment used to treat bacterial infection remain on the surface of the wound for a longer period 
of time as compared with solutions. Also in this case, for highly exuding wounds semi-solid 
preparations are not very effective at remaining on the wound area as they rapidly absorb fluid, 
lose their rheological characteristics and become mobile. 
 
Bandages and gauzes  
Traditional dressings include cotton, wool, natural or synthetic bandages and gauzes. 
Unlike the topical pharmaceutical formulations, these dressings are dry and do not provide a 
moist wound environment. They may be used as primary or secondary dressings, or form part of 
a composite of several layers with each performing a specific function. Gauze is easy to use, 
often readily accessible in most clinics and surgical centers and is inexpensive. Though gauze 
dressings can provide some bacterial protection, this is lost when the outer surface of the 
dressing becomes moistened either by wound exudate or external fluids.
 67
 In addition gauze 
dressings tend to become more adherent to wounds as fluid production diminishes and are 
painful to remove, thus causing patient discomfort. Gauze dressings also provide little occlusion 
and allow evaporation of moisture resulting in a dehydrated wound bed although gauze 
impregnated with soft paraffin is occlusive and easier to remove from the skin. It has been 
suggested that traditional dressings should be employed only for wounds that are clean and dry 
or used as secondary dressing to absorb exudates and protect the wound.
68
 
Traditional wound healing agents have been largely replaced for chronic wounds and 
burns by the more recent and advanced dressings since liquid and semi-solid formulations do 
not remain on the wound surface long enough whilst dry traditional dressings do not provide a 
moist environment for wound healing. 
 
2.2.2. Modern wound dressings 
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Modern dressings have been developed as an improvement upon the traditional wound 
healing systems described above. Compared with standard ones, some advanced wound 
dressings may improve the proportion of wound healed and reduce time to healing, although 
evidence is limited.
69
 Their essential characteristic is to retain and create a moist environment 
around the wound to facilitate wound healing. Dressing choice will be determined mainly by the 
ability of the dressing to achieve the desired exudate level, to assist healing and/or to prevent 
deterioration of wounds not expected to heal. In addition, properties such as fluid retention and 
sequestration may be considered.
70
 
The modern dressings are mainly classified according to the materials from which they 
are produced including hydrocolloids, alginates and hydrogels, and generally occur in the form 
of gels, thin films and foam sheets. 
 
Hydrocolloid Dressings 
Hydrocolloid dressings are among the most widely used dressings. The term 
‘hydrocolloid’ describes the family of wound management products obtained from colloidal (gel 
forming agents) materials combined with other materials such as elastomers and adhesives. 
Typical gel-forming agents include carboxymethylcellulose (CMC), gelatin and pectin.  
 
[FQ1] 
Figure 9: example of hydrocolloidal dressing. 
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Hydrocolloid dressings are useful clinically because unlike other dressings, they adhere to 
both moist and dry sites, and present the advantage of permitting easy visualization without 
disturbing the wound. Hydrocolloid dressings are used for light to moderately exuding wounds 
such as pressure sores, minor burns and traumatic injuries. In their intact state, hydrocolloid 
dressings are impermeable to water vapor but on absorption of wound exudate, a change in 
physical state occurs with the formation of a gel covering the wound. They become 
progressively more permeable to water and air as the gel forms.
71
 As they do not cause pain on 
removal, they are particularly useful in paediatric wound care for management of both acute and 
chronic wounds.
72
 Hydrocolloid dressings generally have an occlusive outer cover that prevents 
water vapor exchange between the wound and its surroundings. This can be disadvantageous for 
infected wounds that require a certain amount of oxygen to heal rapidly. Another disadvantage 
applies to dressings containing fibers that are deposited in the wound and often have to be 
removed during dressing change 
 
 
Hydrogel Dressings 
Hydrogels are insoluble, swellable hydrophilic materials made from synthetic, such as 
poly(methacrylates) and polyvinylpyrrolidine, or natural polymers (es. alginate). Hydrogels can 
be applied either as an amorphous gel or as elastic, solid sheet or film (Figure x). The sheets can 
absorb and retain significant volumes of water upon contact with suppurating wounds, but if 
they are applied in hydrogel form this kind of dressing already contains a significant amounts of 
water (70–90%) and as a result they cannot absorb much exudate, thus they can be used only for 
light to moderately exuding wounds. 
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Figura 10. An example of a polymeric hydrogel sheet wound dressing. Hydrogel sheets do not need a 
secondary dressing and due to their flexible nature, can be cut to fit around the wound. 
 
 
Hydrogels possess most of the desirable characteristics of an ‘ideal dressing’.73 They are 
suitable for cleansing of dry, sloughy or necrotic wounds by rehydrating dead tissues and 
enhancing autolytic debridement. Hydrogel dressings are nonreactive with biological tissues, 
permeable to metabolites and nonirritant.
74
 Hydrogels also promote moist healing, are non-
adherent and cool the surface of the wound, which may lead to a marked reduction in pain and 
therefore have high patient acceptability. Morgan
75
 has stated that hydrogels ‘are suitable for 
use at all four stages of wound healing with the exception of infected or heavily exuding 
wounds’. 
A particular class of hydrogels very used in clinical practice is made by alginates. 
Alginate dressings are comprised of cellulose-like polysaccharides derived from algae or kelp, 
which have impressive absorptive abilities. This type of dressing and all the clinical application 
will be treated in a separate chapter. 
 
Foam Dressings 
These dressings consist of porous polyurethane foam or polyurethane foam film, 
sometimes with adhesive borders. Some foam dressings such as Tielle
TM
 have additional wound 
contact layers to avoid adherence when the wound is dry and an occlusive polymeric backing 
layer to prevent excess fluid loss and bacterial contamination. 
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Figure 11: Example of a foam dressing. 
 
 
Foam dressings maintain a moist environment around the wound, provide thermal 
insulation and are convenient to wear.
76
 They are highly absorbent, absorbency being controlled 
by foam properties such as texture, thickness and pore size. The porous structure of the 
dressings, make them suitable for partial or full-thickness wounds with minimal or moderate 
drainage, to highly absorbent structures for heavily exuding wounds.
77
 Foam dressings are also 
indicated for granulating wounds where they are reported to help treat over granulation. 
 
Biological Dressings and Skin Substitutes 
These dressings are made from biomaterials that play an active part in the wound healing 
process and sometimes referred to as ‘bioactive dressings’. Bioactive wound dressings also 
include tissue engineered products derived from natural tissues or artificial sources. These 
technologies usually combine polymers such as collagen, hyaluronic acid, chitosan, alginates 
and elastin.
1
 Biomaterials have the advantage of forming part of the natural tissue matrix, are 
biodegradable and sometime play an active part in normal wound healing and new tissue 
formation. These characteristics make them attractive from a biocompatibility and toxicological 
point of view. In some cases they may be incorporated with active compounds such as 
antimicrobials and growth factors for delivery to the wound site. 
Traditional and modern dressings though useful, cannot replace lost tissue, particularly 
missing dermis as occurs in severe burns. Advances in the fabrication of biomaterials and the 
culturing of skin cells have led to the development of a new generation of engineered skin 
                                                     
 
 
76
 Wound care guidelines. Medicines Management Committee Report. 2005. 
77
 Thomas S, editor. 1990. Wounds and wound healing in: Wound management and dressings. 
1st edition. London: Pharmaceutical Press. pp 1–14. 
31 
 
 
substitutes.
78
 Such polymers act as scaffolds for tissue engineered substrates that replace lost 
tissue rather than just facilitate wound healing. When introduced into the body they gradually 
degrade, leaving behind a matrix of connective tissue with the appropriate structural and 
mechanical properties. Though these advanced dressings have great potential for treating 
chronic wounds and third degree burns, they are still limited by the high costs involved, the risk 
of infection and antigenicity as well as having to create a second wound in the case of 
harvesting patient’s own cells to aid wound healing. 
 
 
2.3. Medicated dressings for drug delivery 
The use of topical bioactive agents in the form of solutions, creams and ointments may be 
advantageous, but difficult to attain due the issues described before. The introduction of 
dressings for controlled delivery of bioactive species can provide an excellent means to 
concentrate a drug at wound site in a consistent and sustained fashion over long periods of time 
without the need for frequent dressing change. In chronic wound management, where patients 
usually undergo long treatments and frequent changes of dressing, a system that delivers an 
active substance to a wound site in a controlled fashion for a sustained period can improve the 
patient compliance and therapeutical outcome. 
Bioadhesive, synthetic, semisynthetic and naturally derived polymeric dressings are 
potentially useful in the treatment of local infections where it may be beneficial to realize 
increased local concentrations of antibiotics while avoiding high systemic doses thus reducing 
patient exposure to an excess of drug beyond that required at the wound site.
79
 In addition, 
biodegradability can allow them to be easily washed off the wound surface, once they have 
exerted their desired effect. 
 
2.3.1. Polymeric Drug Delivery Dressings  
Most modern dressings are made from polymers which can serve as vehicles for the 
release and delivery of drugs to wound sites The polymeric dressings employed for controlled 
drug delivery to wounds include systems based on synthetic polymers such as poly(lactide-co-
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glycolide), poly(vinyl pyrrolidone), poly(vinyl alcohol), poly(hydroxyalkylmethacrylates), 
polyurethane, or natural hydrocolloids such as hyaluronic acid collagen and chitosan. Also 
synthetic polymers, such as silicone gel sheets, can be employed as swellable dressings for 
controlled drug delivery. Composite dressings comprising both synthetic and naturally 
occurring polymers have also been reported for controlled drug delivery to wound sites.
1
 
By controlling the degree of swelling, crosslinking density, and degradation rate, delivery 
kinetics can be engineered according to the desired drug release schedule.
80
 Drug release from 
polymeric formulations is controlled by one or more physical processes including (a) hydration 
of the polymer by fluids or (b) swelling to form a gel, (c) diffusion of drug through the polymer 
matrix and (d) eventual degradation/erosion of the polymeric system.
81,82
 It seems feasible that 
hydration, erosion and subsequent drug diffusion kinetics will play a part in controlled drug 
release from these dressings when they come into contact with wound exudate. Upon contact of 
a dry polymeric dressing with a moist wound surface, wound exudate penetrates into the 
polymer matrix. This causes hydration and eventually swelling of the dressing to form a release 
system over the wound surface. 
 
 
Figure 12. General scheme for the movement of exudation and drugs during wound healing 
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In certain wound dressings, the mechanism for drug release has been explained by the 
hydrolytic activity of enzymes present in the wound exudates
83
 or from bacteria in the case of 
infected wounds.
84
 
 
2.3.2. Controlled drug delivery to the wound 
Wound dressings can be used to deliver the bioactive molecules to the wound sites. The 
incorporated drugs can play an active role in the wound healing process either directly as 
cleansing or debriding agents for removing necrotic tissue, or indirectly as antimicrobials which 
prevent or treat infection or growth agents (factors) to aid tissue regeneration.  
The purpose of applying antibiotics and other antibacterials is mainly to prevent or 
combat infections especially for diabetic foot ulcers, surgical and accident wounds where the 
incidence of infections can be high due to reduced resistance resulting from extreme trauma.
85
 
Common antibiotics incorporated into available dressings for delivery to wounds include 
dialkylcarbamoylchloride, povidone-iodine and silver, used with most of the modern dressings. 
The delivery of antibiotics to local wound sites may be a preferred option to systemic 
administration because doses needed to achieve sufficient systemic efficiency often results in 
toxic reactions. The use of dressings to deliver antibiotics to wound sites can provide tissue 
compatibility, low occurrence of bacterial resistance and reduced interference with wound 
healing process. The use of low antibiotic doses within the dressings also reduces the risk of 
systemic toxicity considerably. In addition, local delivery from dressings can overcome the 
problem of ineffective systemic antibiotic therapy resulting from poor blood circulation at the 
extremities in diabetic foot ulcers.  
As opposite to antimicrobial agents with support function, growth factors take an active 
physiological role in the wound healing process. These molecules can directly stimulate 
fibroblasts, promote angiogenesis, and encourage cellular proliferation of keratinocytes.
1
 
Topical application of these growth factors to human wounds has shown some benefits in 
animal models and clinical trials.
86
 Different dressings have been used to topically administer 
some of the above growth factors to wound sites. These include hydrogel dressings for 
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delivering transforming growth factor-b1 (TGF-b1),
87
 collagen film for delivering PDGF
88
 and 
human growth hormone,
89
 alginate dressings in the form of beads used to deliver endothelial 
growth factor,
90
 polyurethane and collagen film dressings for delivery of EGF.
91
 
Most of these growth factors are recombinant proteins and are subject to all issues related 
to proteins delivery (high molecular weight, short half-lives, instability, and immunogenicity).
92
 
A molecular genetic approach in which genetically modified cells synthesize and deliver the 
desired growth factor in regulated fashion has been used to overcome the limitations associated 
with the topical application of recombinant growth factor proteins.
93
 Therapy with genes 
encoding for growth factor and/or cytokines used independently or with stem cells may be 
useful in treating wounds resistant to more traditional approaches.
94
  
Another group of active compounds important to the wound healing process are vitamins 
and mineral supplements
95
 including vitamins A, C, E as well as zinc and copper. These 
nutrients are mainly employed as oral supplements to improve wound healing process. 
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 ALGINATE DRESSINGS 
 
3.1. Alginate overview 
Alginates are generally referred to as a family of polyanionic copolymers derived from 
marine kelp, mainly the brown sea algae, discovered by Edward Stanford in 1883. Alginates are 
of growing importance in the healthcare and pharmaceutical industry. Since the first successful 
encapsulation of islet cells by Lim and Sun
96
 (1980), alginate matrices were extensively 
employed as biomaterials for cell culture and transplantation. It’s Their interesting chemical and 
physical properties resulted in many commercial applications, which led to an estimated annual 
production to approximately 38.000 tons worldwide.
97
 The functional role of alginates in some 
common applications are described in several reviews 
98,99
, and summarized in Table 7.  
 
Table 7. Functional role of alginates in some common applications. 
 
Application Function 
Food and beverage industry  
Drinks Stabilizers, thickeners 
Ice-cream Stabilizers, thickeners 
Jelly Stabilizers, thickeners 
Ethanol production Encapsulation material of yeast cells 
Pharmaceutical industry  
Cell culture and transplantation Encapsulation material 
Dental impression material Mould 
Tablets Adhesive agent, sustained-release 
Wound dressing Haemostatic and absorbent 
Other industries  
Fabrics Thickeners 
Paper Adhesive agent, filler 
Paint Stabilizer and suspending agent 
Toothpaste Stabilizers, thickeners 
 
Commercially available alginate is typically extracted from brown algae (Phaeophyceae), 
including Laminaria hyperborea, Laminaria digitata, Laminaria japonica, Ascophyllum 
                                                     
 
 
96
 Lim F. and Sun A.M. Science. 1980 
97
 Andersen T., Strand B.L., Formo K., Alsberg E. et al. Carbohydrate Chemistry. 2012 
98
 Wee S. and Gombotz W.R. Adv.Drug Deliv.Rev. 1998 
99
 Chapman V.J. and Chapman D.J. Algin and alginates. in Seaweeds and their uses. 1980 
36 
 
 
nodosum, and Macrocystis pyrifera
100
 by treatment with aqueous alkali solutions, typically with 
NaOH.
101
 Bacterial biosynthesis may provide alginates with more defined chemical structures 
and physical properties than can be obtained from seaweed-derived alginate. Bacterial alginate 
can be produced from Azotobacter and Pseudomonas. 
Alginate is a whole family of linear copolymers containing blocks of (1,4)-linked β-d-
mannuronate (M) and α-l-guluronate (G) residues. The uronic blocks are composed of 
consecutive G residues (GGGGGG), consecutive M residues (MMMMMM), and alternating M 
and G residues (GMGMGM) (figure 13). The proportion and arrangement of the uronic blocks 
vary with the source and are related to the physical strength and other physical properties of the 
alginate structure.
102
  
 
 
Figure 13. Chemical structure of G-block, M-block, and alternating block in alginate 
 
 
The structural–property relationships of alginates are better understood, owing to 
extensive research and wider pharmaceutical applications in recent years. Physical properties of 
alginates are largely governed by the composition and arrangement of the uronate residues, 
molecular weight of the polymer and presence of cations that, depending on type, can cross link 
separate chains.
103
 Alginates with a wide range of molecular weights (MWs, 50–100 000 kDa) 
can be dispersed in aqueous solutions giving non-Newtonian fluids, i.e. the viscosity decreases 
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with increasing shear rate (shear thinning). The viscosity of an alginate solution depends on the 
concentration of the polymer and the MW distribution.
104
 
Since alginate is obtained from natural sources, various impurities such as heavy metals, 
endotoxins, proteins, and polyphenolic compounds could potentially be present. The 
immunogenic response at the injection or implantation sites might be attributed to impurities 
remaining in the alginate and Orive et al. 
105
 demonstrated that the alginate purified by a multi-
step extraction procedure to a very high purity did not induce any significant foreign body 
reaction when implanted into animals. Similarly, no significant inflammatory response was 
observed when gels formed from commercially available, highly purified alginate have been 
subcutaneously injected into mice.
106
 Furthermore, the immunological properties of alginates 
can be related to the sequential structures and molecular size of the polymer too.
107
 
108
 High 
mannuronic-containing alginate residues appeared to be involved in a receptor-mediated 
mechanism that stimulated and released cytokine in wounds while a high content of guluronic 
acid suppressed this activity.
109
 Alginates with high mannuronic content were reported to show 
greater biocompatibility and recommended as suitable biomaterials for implants.
110
 Although 
the biocompatibility of alginate has been extensively evaluated in vitro as well as in vivo, there 
is still debate regarding the impact of the alginate composition.  
 
 
3.2. Alginate hydrogels  
Alginate is typically used in the form of a hydrogel in biomedicine, including wound 
healing, drug delivery and tissue engineering applications. Hydrogels are three-dimensionally 
cross-linked networks composed of hydrophilic polymers with high water content. Hydrogels 
are often biocompatible, as they are structurally similar to the macromolecular-based 
components in the body, and can often be administered via minimally invasive procedures.
111
 
Chemical and/or physical cross-linking of hydrophilic polymers are typical approaches to form 
hydrogels, and their physicochemical properties are highly dependent on the cross-linking type 
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and cross-linking density, in addition to the molecular weight and chemical composition of the 
polymers.
112
 
Alginate hydrogels can be covalently cross-linked using carbodiimide chemistry. 
Chemically cross-linked are more stable and have good mechanical properties, but the reagents 
may be toxic, and the unreacted chemicals may need to be removed thoroughly from gels. 
Covalent cross-linking has been widely investigated in an effort to improve the physical 
properties of gels for many applications, including tissue engineering. Photo cross-linking is 
another approach to achieve in situ gelation that exploits covalent cross-linking. Photo 
crosslinking can be carried out in mild reaction conditions, even in direct contact with drugs and 
cells, with the appropriate chemical initiators. Photo cross-linking reactions typically involve 
the use of a light sensitizer or the release of acid, which may be harmful to the body. 
The most common method to prepare hydrogels from an aqueous alginate solution is to 
combine the solution with ionic cross-linking agents, such as polyvalent cations. This cations 
can replace and be preferentially bound to the binding sites of the residing sodium ions in the 
polyguluronate segments and produce a cross-linked “egg-box” model (figure x).113,114 In 
general, divalent cations (Cd
2+
, Co
2+
, Cu
2+
, Mn
2+
, Ni
2+
, Pb
2+
 and Zn
2+
) are suitable crosslinking 
agents while monovalent cations or Mg
2+ 
are not.
115
 Usually, Ca
2+
 is the most commonly used 
divalent cations used to ionically cross-link alginate and calcium chloride (CaCl2) is one of the 
best choices. 
 
 
 
Figure 14. egg-box model  
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The chelation at the G-residue of the alginate chains results in ionic interaction between 
the guluronic acid groups while the van der Waal forces between alginate segments and 
formation of a three-dimensional gel network
116,117
. The composition of the guluronic segments 
(molecular weight and M/G ratio) and hence the extent of cross-linking will largely affect the 
quality of the matrices formed. When gels are made from an alginate rich in guluronic acid residues, 
higher gels strength are obtained, which is an indicator of the mechanical stability of cross-linked 
matrices.
118
 The proposed explanation for this behavior is that high-G gels, with their long G blocks and 
their short elastic segments become more of a stiff open and static network compared to the more 
dynamic and entangled network structure of the low-G gels with their relative long elastic segments
119
 
(Figure x). 
 
 
Figure 15. Proposal model for network structure in gel made from alginates with G blocks at different 
length. Adapted from Draget et al.
120
 
 
 
In particular, the Alginate matrices made from a high content of guluronic acid tend to be 
rigid and brittle, while more elastic gels are produced from alginates of low α-l-guluronic acid 
content.
121
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Cross-linking metal ions show different affinities for alginates although the extent of 
cross-linking may be influenced by the chemical composition of alginates. 
The gelation rate is a critical factor in controlling gel uniformity and strength when using 
divalent cations, and slower gelation produces more uniform structures and greater mechanical 
integrity.
122
 The gelation temperature also influences gelation rate, and the resultant mechanical 
properties of the gels. At lower temperatures, the reactivity of ionic cross-linkers (e.g., Ca
2+
) is 
reduced, and cross-linking becomes slower.
123
 
Generally, the formation of cross-linked alginate gel matrices can occur by three 
mechanisms, namely external gelation, internal gelation, and gelation by cooling. In the 
formation of large pellets or micropellets by external gelation, the drug-containing alginate 
solution is delivered to the cross-linking solution as extruded or atomized droplets and gel 
formation occurs as cross-linking cations diffuse into the alginate solution. In the internal 
gelation method, an insoluble calcium salt (e.g. calcium carbonate) is first added to the alginate 
drug solution and free calcium ions are subsequently liberated by pH adjustment.
124
 For 
alginates formed by cooling, the alginate chains at high temperature prevented polymeric 
alignment and irreversibly destabilized any non-covalent intra-molecular bonding between 
neighboring chains.
125
 Upon cooling at a lower temperature, the reestablishment of the inter-
molecular bonds between the polymer chains facilitated the formation of an ordered tertiary 
structure and resultant homogeneous matrix. 
One critical drawback of ionically cross-linked alginate gels is the limited long-term 
stability in physiological conditions. The ionotropic gelation of alginates is inherently a 
reversible process because these gels can be dissolved due to release of divalent ions into the 
surrounding media due to exchange reactions with monovalent cations. In addition, the calcium 
ions released from the gel may promote hemostasis, while the gel serves as a matrix for 
aggregation of platelets and erythrocytes.
126
 These features may be beneficial or negative, 
depending on the situation. 
 
3.3. Alginate dressings 
                                                     
 
 
122
 Kuo C.K. and Ma P.X. Biomaterials. 2001. 
123
 Augst A.D., Kong H.J. and Mooney D.J. Macromol.Biosci. 2006. 
124
 {Chan, 2006 675 /id} 
125
 {Papageorgiou, 1994 674 /id}. 
126
 {Suzuki, 1998 676 /id} 
41 
 
 
The ability of calcium ions to form crosslinks with alginates makes calcium alginate 
dressings ideal materials as scaffolds for tissue engineering.
127
 Alginate dressings occur either in 
the form of freeze-dried porous sheets (foams) or as flexible fibres, the latter indicated for 
packing cavity wounds. The use of alginates as dressings stems primarily from their ability to 
form gels upon contact with wound exudates (high absorbency). The high absorption occurs via 
strong hydrophilic gel formation, which limits wound secretions and minimizes bacterial 
contamination.
1
 When applied to wounds, ions present in the alginate fibers are exchanged with 
those present in exudate and blood to form a protective film of gel. This helps to maintain the 
lesion at an optimum moisture content and healing temperature. Also in this case the 
composition of alginate gives different properties to the dressing: alginates rich in mannuronate, 
such as Sorbsan
TM
 (Maersk, UK) form soft flexible gels upon hydration whereas those rich in 
guluronic acid, like Kaltostat
TM
 (ConvaTec, USA), form firmer gels upon absorbing wound 
exudate.  
Currently, the use of alginates in wound care relies largely on the clinical knowledge that 
alginates promote healing through a moist environment. The wide acceptance of alginates in 
wound healing is also related to the positive clinical advantages shown in various studies. A 
prospective, randomized, controlled trial involving patients with full-thickness pressure ulcers 
reported better clinical outcome using alginate wound dressing when compared to topical 
treatment with a dextranomer paste.
128
 Treatments with calcium alginate dressings had shown 
good healing outcomes in various types of skin wounds
129,130,131,132,133,134,135,136
 and animal 
model.
137
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Figure 16. Use of different alginate dressing in wound healing 
 
 
3.3.1. Role of calcium and zinc in wound healing 
Alginate dressings, as well as derived gels, have a pharmacological function in all the 
wound healing phases, due to the action of the calcium ions present inside the dressing.
138
 Those 
ions, when released into the wound, play a physiological role aiding in the clotting mechanism 
(hemostat) during the first stage of wound healing.
139,140,141 
Furthermore calcium alginate shows 
also a direct action on cellular mechanism of wound healing. Schmidt and Turner
142
 and Doyle 
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et al.
143
 showed that calcium alginate increased proliferation of mouse fibroblasts but not their 
motility in vitro and Thomas et al.
144
 have reported that some alginate dressings activate human 
macrophages to produce tumor necrosis factor-α (TNFα) which initiates inflammatory signals, 
as part of the wound healing process. Zinc-containing alginate dressings were also shown to 
possess greater potentiating effect on prothrombotic coagulation and platelet activation than 
calcium.
145
 This may be related to the role of zinc ions as a cofactor for the coagulation factor 
XII and the intrinsic pathway of coagulation. Further support was found in the study by 
Kowalska et al.
146
, reporting enhanced zinc ion aggregation to adenosine diphosphate (ADP) 
during wound healing. These evidences suggest that the effects of the dressing may have been 
mediated by ions released from the alginate and therefore calcium or zinc alginate may improve 
some cellular aspects of wound healing. 
Calcium alginate dressing have been claimed to have antimicrobial properties in wound 
management, but clinical studies showed no evidence to support this use.
147
 Divalent cations 
such as Cu
2+
 and Zn
2+
 were found to exhibit higher anti-microbial activities than Ca
2+
 against 
the skin pathogens S. aureus and P. aeruginosa and were generally compatible with common 
topical anti-microbial agents
148
. 
 
 
3.3.2. Clinical use of alginate dressings 
Since the first clinical use by Major George Blaine in the 1940s,
149
 many useful 
applications of alginates are included in wound care management. Alginates can be made into 
various forms such as sponges, films and extrudates (woven or nonwoven dressing) depending 
on the process of cross-linking and several commercial products of alginate-based dressings are 
available. Alginate dressings are useful for moderate to heavily exuding wounds because they 
can absorb large volumes of exudates while providing an adequately moist environment for 
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wound healing.
150
 The absorbent ability of the dressing can be affected by the constitution of the 
fibers, relative proportions of mannuronic and guluronic acid residues, and content of calcium 
and sodium ions.
151
 Dressings with high mannuronate content are capable of greater uptake of 
moisture but the fibers are characteristically weaker.
152
 Since alginate dressings require moisture 
to function effectively, they cannot be used for dry wounds and those covered with hard necrotic 
tissue. This is because it could dehydrate the wound, delaying healing, which represents a major 
disadvantage.
1
 
One important consideration of a wound dressing will be its mechanical integrity. The 
dressing should be sufficiently strong during the intended use. It was reported that the 
composition of the alginates (mannuronate to guluronate or M/G ratio) influenced the physical 
attributes of the fibers formed
153
. However, alginate dressings in the form of fibers when 
trapped in a wound are readily biodegraded and can be rinsed away with saline irrigation. 
Subsequent removal therefore, does not destroy granulation tissue, making dressing change 
virtually painless. 
The present interest in alginates for wound care management involves an understanding 
of the advantages of alginates and the strategies are largely targeted at improving their 
functionality as a wound healing promoter. Moreover with the advent of tissue engineering, 
extensive work has been done to integrate wound healing components/cells with biocompatible 
polymers to provide an environment capable of sustaining viable cells for tissue repair
154
.  
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Table 8. Alginate dressing currently available on the market in Italy 
 
Commercial 
name 
Composition Therapeutic indication Contraindications Interactions 
ALGISITE M Calcium alginate 
fiber dressing 
Partial and total thickness lesions 
with moderate to high exudate, and 
tending to minor bleeding, such as: 
sores, ulcers of the lower limbs, 
surgical wounds, diabetic ulcers, 
cancer lesions , burns. 
Known allergy to 
alginate dressings. 
Hemostasis in 
profusely bleeding 
wounds 
Unknown 
interactions  
ALGOSTERIL Calcium alginate 
fiber dressing 
Wounds with medium / high 
exudate: chronic wounds (leg 
ulcers, pressure ulcers, diabetic 
foot), deep wounds, bleeding 
wounds, infected and 
desquamating wounds. 
Unknown 
controindications 
Unknown 
interactions 
CURASORB Calcium alginate 
dressing 
Venous ans arterial stasis ulcers, 
sores, diabetc ulcers, lacerations, 
abrasions, surgical incisions, 
second degree burns and other 
external wounds with moderate 
exudate. Can be used on infected 
wounds only if replaced at least 
once a day. 
Do not use on third 
degree burns and 
heavily bleeding 
injuries. 
Unknown 
interactions 
KALTOSTAT Calcium sodium 
alginate dressing 
Moderately to highly exuding 
chronic and acute wounds, and for 
wounds with minor bleeding. 
Exuding wounds such as diabetic 
ulcers, venous stasis ulcers, 
bedsores, skin donor sites, 
superficial wounds and abrasions, 
superficial burns, cancer wounds 
Known allergy to 
alginate dressings or 
one of their 
component. Third 
degree burns, heavily 
bleeding injuries. 
Small exudating 
injuries 
Unknown 
interactions 
MELGISORB Calcium sodium 
alginate dressing 
Moderately to highly exuding 
chronic and acute wounds. 
Exuding wounds such as diabetic 
ulcers, venous stasis ulcers, 
bedsores, Superficial wounds and 
abrasions, skin donor sites, 
superficial burnsand other acute 
skin lesions 
Do not use on dry 
wound and Third 
degree burns 
Unknown 
interactions 
SEASORB Calcium sodium 
alginate and 
carboxymethylcell
ulose dressing 
Indicated for the management of 
moderate to heavily exuding 
wounds such as pressure ulcers, leg 
ulcers, diabetic ulcers, second-
degree burns, grafts, skin donor 
sites or traumatic wounds. Local 
hemostatic effect 
Do not use on dry 
wound with no 
exudate. Inaffective 
for bleeding 
management of 
surgical wound 
Unknown 
interactions 
SUPRASORB A Calcium sodium 
alginate dressing 
Indicated for the management of 
moderate to heavily exuding 
wounds. 
Unknown 
controindications 
Unknown 
interactions 
TEGADERM 
ALGINATE 
Calcium alginate 
fiber dressing 
Partial and total thickness lesions 
with moderate to high exudate, and 
tending to minor bleeding. 
Do not use on dry 
wound, surgical 
implants and Third 
degree burns 
Unknown 
interactions 
ASKINA SORB Calcium alginate 
and hydrocolloyd 
Indicated for the management of 
moderate to heavily exuding 
Do not use on surgical 
implants and Third 
Topical treatment 
with antimicrobial 
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(carboxymethilcell
ulose) dressing 
wounds, also in presence of 
infection. Exuding wounds such as 
diabetic ulcers, venous stasis 
ulcers, bedsores, skin donor sites, 
superficial wounds and abrasions, 
superficial burns, cancer wounds 
degree burns or antiseptics. In 
case of anaerobial 
bacteria it shouldn’t 
use with an 
occlusive dressing 
CURASORB ZN Calcium-zinc 
alginate dressing 
Use as secondary dressing in case 
of external wounds such as diabetic 
ulcers, venous stasis ulcers, 
bedsores, or similar wounds.  
Do not use on third 
degree burns and 
heavily bleeding 
injuries. 
Unknown 
interactions 
FARMACTIVE 
ALGINATO 
Calcium alginate 
and 
carboxymethilcellu
lose dressing 
Not available  Not available  Not available  
HYALOGRAN Calcium alginate 
and Hyaff 
(hyaluronic acid 
ester) 
Necrotic lower limb Necrotic 
ulcers, surgical wounds and 
bedsores. Useful in wound with 
diffused necrotic tissue  
Known allergy to 
alginate dressings. In 
presence of infection 
the dressing should be 
daily changed 
Unknown 
interactions 
SORBALGON 
SORBALGON T 
Calcium alginate 
and polysorbate 
Indicated for the management of 
moderate to heavily exuding 
wounds or bleeding wounds, such 
as pressure ulcers, leg ulcers, 
diabetic ulcers, severe burns, 
grafts, extended surgical wounds 
Unknown 
controindications 
Unknown 
interactions 
SUPRASORB 
A+AG 
Calcium alginate 
and silver 
Indicated for infected and heavily 
exuding wounds, such as pressure 
ulcers, leg ulcers, diabetic ulcers, 
severe burns, extended surgical 
wounds.  
Known allergy to 
alginate dressings. 
Avoid contact with 
conductive gel or 
electrodes during 
ECG, EEG 
measurements Not 
use in patients 
subject to Magnetic 
Resonance.  
URGOSORB Calcium alginate 
and hydrocolloyd 
(carboxymethilcell
ulose) dressing 
Indicated for the management of 
moderate to heavily exuding 
wounds, during the wound 
cleaning and the granulation phase 
Used as nasal swabs. 
Use with caution on 
poorly exuding 
wounds, third-degree 
burns and in leg ulcers  
Unknown 
interactions 
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ALGINATE – HYALURONIC ACID HYBRID 
HYDROGELS AD SPONGES FOR WOUND 
HEALING 
 
 Introduction 
Wound repair of is one of the most complex biological processes that occur during human 
life. After an injury occurs, various intracellular and intercellular pathways need to be activated 
and coordinated if tissue integrity and homeostasis are to be restored.
155
 Dressings have been 
applied to open wounds for centuries to prevent wound from further injury and bacteria 
invasion, but nowadays their design has evolved toward multifunctionality, that is to better 
control potential infection and to aid healing process.
156
 A key property of modern dressings is 
their ability to retain and create a moist environment around the wound which is expected to 
facilitate healing. Amid modern dressings, hydrogels cover a large area due to their well-
recognized compatibility.
1
 Above their glass transition temperature, hydrogels are typically soft 
and elastic due to their thermodynamic compatibility with water and useful in many different 
biomedical applications.
157,158 
Hydrogels have shown excellent potential in a variety of 
biomedical applications, including scaffolds for tissue engineering or carriers for drug delivery 
systems.
159
  
Alginates include a whole family of water-soluble polysaccharides extracted from brown 
seaweed. ALGs are linear copolymers containing blocks of (1,4)-linked β-d-mannuronate (M) 
and α-l-guluronate (G) residues. These blocks are composed of consecutive G residues 
(GGGGGG), consecutive M residues (MMMMMM), and alternating M and G residues 
(GMGMGM). The proportional and sequential arrangements of the M and G residues depend 
upon the type of algae tissue from which the polysaccharide is extracted, as well as on the 
season in which the algae is collected and more than 200 different ALGs are currently being 
manufactured.
160
 Due to its biocompatibility and bioresorption properties, ALGs has been 
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widely used in regenerative medicine.
161
 ALG dressings offer a series of advantages and for this 
reasons they have been successfully applied to cleanse a wide variety of secreting lesions. The 
high water absorption occurs via strong hydrophilic gel formation, which limits wound 
secretions and minimizes bacterial contamination.
162
 Furthermore, ALG dressings maintain a 
physiologically moist microenvironment that promotes healing and formation of granulation 
tissue. ALGs can be rinsed away from wound bed with saline irrigation, so removal of the 
dressing does not interfere with healing granulation tissue. This makes dressing changes 
virtually painless. Another important aspect of the wound healing process is related to wound 
exudate management, particularly with respect to controlling maceration of peripheral tissue. 
ALG dressings can be designed to absorb large volumes of exudate, whilst continuing to 
provide a moist wound healing environment and thus they well adapt to management of 
moderate to heavily exudating wounds.
163
 ALG-based absorbent wound dressing may be used 
on multiple wound types, including but not limited to diabetic wounds, venous wounds, 
pressure ulcers, cavity wounds, and some bleeding wounds. 
Ionically cross-linked ALG hydrogels can be formed in the presence of several divalent 
cations such as Ca
2+
, Ba
2+
, Sr
2+
, Zn
2+
, Cu
2+
, Cd
2+
, and Co
2+
.
164
 Divalent cations allow interchain 
interactions between G-rich regions of one polymer chain with the G-rich regions of adjacent 
polymer chains in what is termed the ‘egg-box’ model of cross-linking resulting in hydrogel 
formation.
165
 Soluble calcium salts are widely employed to cross-link ALGs (in solution or 
solid). These methods typically leads to rapid and inadequately controlled gelation that results 
in the formation of hydrogels with scarce structural homogeneity and poor mechanical 
properties.
166,167
 To overcome this drawback, internal gelation of ALG through CaCO3-GDL (D-
glucono-δ-lactone) system has been attempted and found very useful to obtain homogenous 
hydrogel useful as scaffolding materials for wound healing applications. The kinetics of the 
gelation process has been studied extensively
168
 and it has been found to be affected by alginate 
concentration, composition, and particle size of the calcium salts.  
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Hyaluronan (HA) is a nonsulfated, linear glycosaminoglycan (GAG), consisting of 
repeating units of (b, 1–4) glucuronic acid-(b, 1-3)-N-acetyl glucosamine. HA is present in most 
living tissues as a high molecular mass polymer ( > 100 kDa) and in significant amounts in the 
skin (dermis and epidermis), brain, and central nervous system. Toole B.P. Nat.Rev.Cancer. 
2004 HA has a crucial role in tissue repair, including wound healing.
169
 Several studies have 
shown that exogenous HA exerts beneficial effects on the wound-healing process. Topically 
applied HA has been shown to accelerate skin wound healing in rats
170
 and hamsters
171
. HA may 
also play a role in the control of angiogenesis during tissue repair.
172
 In addition, it has been 
proposed that HA may protect granulation tissue from oxygen free radical damage by its ability 
to scavenge reactive oxygen species (ROS),and that it could reduce the deleterious effect of 
oxygen free radical on wound healing.
173
 HA and its fragments may play crucial roles in the 
skin wound-healing process, by modulating the expression of fibroblast genes involved in 
remodeling and repair of extracellular matrix (ECM).
174
 However, the detailed mechanisms of 
how HA exerts its biological effects is far to be elucidated.  
The main objective of this study was to develop a ALG/HA hydrogel with functional 
properties with potential use as wound dressing. Internal gelation technique was used for cross-
linking ALG/HA solutions. Hydrogels were shaped as discs and characterized as hydrated 
system or dry system. Finally, biocompatibility and wound healing properties were evaluate on 
human adipocyte-derived Mesenchimal Stem Cells. 
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 Materials and methods 
2.1. Materials  
Sodium alginate (ALG) (viscosity 360cps) was purchased from Farmalabor (Italy). 
Analysis-grade ethanol was purchased from Carlo Erba (Italy). Hyaluronic acid (HA) sodium 
salt from Streptococcus equi (1.5-1.8 * 10
6
 Da), tranexamic acid (TA), calcium carbonate 
(CaCO3), calcium chloride dihydrate (CaCl2 * 2H2O), sodium chloride (NaCl), potassium 
chloride (KCl), sodium phosphate dibasic (Na2HPO4), D-glucono-δ-lactone (GDL) and all 
reagents used for sulforhodamine assay were obtained from Sigma-Aldrich (St. Louis, MO). 
Media, sera, and antibiotics for cell cultures were from Lonza (Lonza Group Ltd, Basel, 
Switzerland). The water used throughout this study was depurated and filtered (Millvi Q filter).  
 
2.2. Determination of the chemical composition of Alginate by 1H 
NMR spectroscopy 
The chemical composition of ALG, the M/G ratio and the sequence of the blocks along 
the polymeric chain determine its functional properties, including the solubility, viscosity and 
gelification.
175,176
 The chemical composition of ALG was assessed by 
1
H nuclear magnetic 
resonance (NMR) spectroscopy. The 
1
H NMR spectra of ALG in solution were recorded on a 
NMR spectra were recorded on a Varian INOVA 700 MHz spectrometer (Varian inc., USA) 
equipped with a z-gradient 5mm triple-resonance probe head. All the spectra were recorded at a 
temperature of 25 and 45 °C. The spectra were calibrated relative to TSP (0.00 ppm) as internal 
standard. Prior to analysis, the molecular weight and the viscosity of the ALG were reduced by 
a mild partial acid hydrolysis, using 1 M HCl solution, according to the ASTM Standard F 
2259.
177
 
 
2.3. ALG/HA hydrogel preparation 
Structurally homogeneous calcium Alginate gels were made as previously described by 
Kuo and Ma.
178
 Briefly ALG (1% for hydrogels and 2% for sponges w/v) was dissolved in 
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deionized water and mixed with calcium carbonate (CaCO3) 30mM to form a suspension. A 
fresh aqueous 64 mM GDL solution was then added to the suspension and vortexed to initiate 
gelation. A CaCO3 to GDL molar ratio of 0.5 was maintained to achieve a neutral pH post-
crosslinking. The HA was dissolved directly in the alginate solution to obtain the concentrations 
of 10% and 20% w/w. The solutions were cast in 96 well plate (50 µl, well size: 5 mm diameter, 
20 mm height) to form circular discs 2 mm in thickness and 5 mm in diameter or in a 24-well 
plate (1 ml, well size: 15mm diameter, 20mm height) to form circular discs 5 mm in thickness 
and 15 mm in diameter, depending on use. The well plate were capped, sealed with Parafilm
®
, 
and gelled on a leveled plate at room temperature for 24 h. After gelation the ALG disc were 
washed with water and stored at 4°C. 
 
 
2.4. ALG/HA sponge preparation 
To obtain a structurally homogenous ALG/HA sponge with useful properties for drug 
delivery, was prepared a 2% w/v ALG solution and gelled with the previously described method 
in a 24-well plate. This hydrogels was frozen overnight at −40◦C, and then lyophilized at 0.01 
atm and -60°C in a Modulyo apparatus (Edwards, UK). After lyophilization the ALG sponge 
were stored at room temperature under vacuum.  
To obtain TA loaded Alg/HA sponges, 10 mg of TA were dissolved in ALG solution for 
each well. 
 
2.5. Hydrogel characterization 
The viscosity of ALG/HA colloidal dispersions was evaluated using a Brookfield 
viscometer model DV8+pro using the impeller 61. The rotation speed used for this experiment 
was 3 RPM. 
Homogeneity of the cylindrical ALG gels was characterized with dry to wet weight 
ratios. Gels were cut perpendicular to the cylinder axis into 4 slices with approximately the 
same thickness. The slices were labeled 1-4 from top to bottom. After measuring their wet 
weights, the slices were dried at 45° C for 48 h. The specimens were weighed again after 
drying, and their dry/wet weight ratios were calculated. The averages and the standard 
deviations of triplets were reported. 
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Gelation time was assessed using a method adapted from Kuo and Ma.
179
 Gelation time 
was defined as the time between the addition of GDL and the formation of the gel. Briefly the 
sodium ALG solution was added to CaCO3 suspension in H2O, mixed and vortexed, and 
transferred into vials for each sample. The suspensions were allowed to equilibrate to the room 
temperature for 45 min. A fresh aqueous GDL solution were subsequently added to each 
sample. The final suspension was vortexed for 20 s. The gel was said to be formed when the 
sample no longer flowed when tilted at an angle of 45° for longer than 30 s The averages and 
the standard deviations of triplets were reported. 
Cross-linking degree of the ALG hydrogels was evaluated by soaking the hydrogel gel 
disc was in 15 mL of 1, 3 and 5 mM solution of CaCl2*2H2O to varying calcium ion 
concentrations. The swelling experiments were carried out at 37° C in high humidity by keeping 
the samples in a thermostatic bath under gentle shaking. The medium was changed every day. 
At the scheduled times, the specimens were retrieved and hydrogel surfaces were quickly 
blotted twice on a filter paper. The specimens were weighed on an analytical balance accurate to 
10
-4
 g. The initial wet weight (W0) was obtained after 24 h gelation. Wet weight (W) during 
immersion experiment was recorded at designated times. The swelling ratio was defined as 
W/W0. Samples were tested in triplets. Averages and standard deviations are reported. 
 
2.6. Sponge characterization 
The bulk morphology of the ALG/HA sponge was analyzed through scanning electron 
microscopy (SEM). The samples were stuck on a metal stub and coated with gold under vacuum 
evaporator for 90–120 s. Images were obtained using Quanta 200 FEG (FEI, USA). 
The average porosity of ALG/HA sponge was determined by a fluid replacement 
method.
180
 Ethanol was chosen as the displacement liquid because it penetrates easily into the 
pores and did not induce shrinkage or swelling. The geometrical volume (Vs) of the sponge 
samples was calculated by measuring diameter and height, and the pore volume (Vp) was 
measured by ethanol displacement method. The dry sponge was weighed (W0) and immersed in 
absolute ethanol at room temperature, and then placed in a degasser for 5 min to remove air 
bubbles from the sponge pores. After wiping gently with a filter paper to remove surface 
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ethanol, samples were weighed immediately (We). The porosity of the sponge was calculated 
according to the following equation: 
 
  
  
  
        
      
    
       
 
where ρe represents the density of ethanol (0.789 g/cm
3
). An average value of five replicates for 
each sample was taken. 
The density (ρ) of the sponge was calculated according to the following equation:  
 
  
  
  
 
 
Hydration properties of sponges have been evaluated by means of modified Enslin 
apparatus employing Phosphate Buffer Saline (PBS, NaCl 120 mM, KCl 2.7 mM, Na2HPO4 10 
mM) at pH 7.4
181
 as hydration medium. PBS was used as hydration medium to simulate 
biological fluids in tissue injuries. Three replicates were performed for each sample. 
The in vitro release profile of tranexamic acid (TA) from ALG and ALG/HA sponge 
matrix was evaluated in Phosphate Buffer Saline (PBS, NaCl 120 mM, KCl 2.7 mM, Na2HPO4 
10 mM) at pH 7.4. TA loaded sponge were incubated in 10 ml of PBS and placed in a 
thermostatic bath at 37 C. At scheduled time intervals, the release medium was withdrawn and 
replaced with the same volume of fresh filtered medium. The supernatant was analyzed for TA 
content by an indirect method using a UV-vis spectrophotometer after derivatization with 
fluorescamine.
182
 Briefly, TA samples were diluted 1:2 by volume in a fluorescamine solution at 
0.5% (w/v) in ethanol and incubated in the dark at room temperature for 1 hour before analysis. 
The absorbance (ABS) of TA samples was measured at 390 nm using a Shimadzu 1800 
spectrophotometer (Shimadzu, Japan) fitted out with a 1 cm quartz cell (Hellma,
,
Germany). The 
linearity of the response was verified over the concentration range 5–100 μg/ml (r2≥0.999).  
To measure the water retention rate, sponge sample soaked in water for 30 min then 
carefully removed and placed in a centrifuge tube. The sponge was centrifuged at 3500 rpm for 
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3 min to eliminate the excess of water, and the wet weight was recorded. Water retention rate 
(WR) was calculated with the following formula: 
 
   
     
  
       
 
Where Mh (g) is the weight of the sponge after centrifugation, and Md (g) is the initial dry 
weight. An average value of five replicates for each sample was taken. 
 
2.7. Water uptake of hydrogels and sponges 
Water uptake was determined by placing the cross-linked freeze-dried sponges in water. 
Three circular samples of 15 mm diameter were obtained from a 24 well plate. The initial 
weight of each sample was recorded using an analytical balance. The samples were placed in 5 
mL of water at a temperature of 37 °C maintained by a water bath. Samples were taken out and 
excess water was removed using tissue paper and after having been weighed were re-immersed 
in water. The samples weight was recorded at intervals of 1h up to 6h and every 24 h from there 
onwards until equilibrium was established. Water was replaced after every weight. The swelling 
ratio per cent (SR %) at each time point was calculated by the equation 
 
      
    
  
       
 
where W is the mass of the swollen sample and W0 is the mass of the initial dry sample. The 
equilibrium water content (EWC) per cent was calculated by the equation: 
 
    ( )   
       
  
      
 
where We is the mass of the swollen sample at equilibrium and Wd is the mass of the dry sample 
at equilibrium. 
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2.8. In vitro toxicity of hydrogels: Human adipose tissue-derived 
mesenchymal stem cell culture and viability.  
Human adipose tissue biopsies were digested with collagenase and Mesenchymal Stem 
Cell (Ad-MSC) were isolated as previously reported.
183
 Ad-MSC were cultured at 37°C with 
Dulbecco's modified Eagle's medium (DMEM) and Ham's F12 (1:1) with 10% FBS, 2 mM 
glutamine, 100 IU/ml penicillin, and 100 IU/ml streptomycin. Cultures were maintained in 
humidified atmosphere of 95% air and 5% CO2 at 37° C.  
Ad-MSC viability was assessed using 0.4-μm pore polycarbonate membranes (Costar, 
Cambridge, MA). Cells were loaded at 50,000 cells per insert in the lower chamber. The 
following day, the hydrogels were added to the upper chamber in DMEM F12 (1:1) 10% FBS. 
Upon 24h, sulforhodamine assay was used for determination of cell viability.
184
 Briefly, the 
upper chamber was removed and the cells were fixed with 50% trichloroacetic acid for at least 2 
h at 4 C. Then, cells were washed 5 times with distilled and de-ionized water. After air drying, 
cells were stained for 30 min with 100 μl 0.4% sulforhodamine dissolved in 1% acetic acid. 
Unbound dye was removed by five washes with 1% acetic acid. After air drying, 10 mM Tris 
solution (pH 7.5) was added to dissolve the protein-bound dye. Cell survival was assessed by 
optical density (OD) determination at 510 nm using a microplate reader. Three replicate wells 
were used for each data point, and the experiment was performed three times.  
 
2.9. Cell motility - Wound healing Assay 
Ad-MSC were seeded into six-well microplates and grown in a complete medium to a 
confluent monolayer. Then, the cells were wounded by manually scratching with a p20 pipette 
tip. Reference points near the “scratch” were marked to guarantee the same area of image 
acquisition. The wells were washed twice with phosphate buffered saline (PBS) and incubated 
at 37 C with hydrogels. Images of wound gap were taken at 0 and 24 h by a digital camera 
coupled to the microscope and percentage of closure was calculated with NIH IMAGE J. These 
experiments were repeated at least three times. 
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 Results and discussion 
 
3.1. Characterization of Alginate  
The chemical composition of ALG, which can vary with the material batch and producer, 
can greatly influence its properties. Indeed, the affinity of certain ions with the G units, the M/G 
ratio and the number of repeated sequential G and M units strongly affect the gelation process 
and, in turn, hydrogel physical structure (strength and porosity).. The analysis of the chemical 
composition of the raw ALG powder used, allowed to quantify the M/G ratio and the sequence 
of the blocks along the polymeric chain, which influence the properties of the resulting 
hydrogels. M/G ratio and the block structure were determined by 
1
H NMR spectroscopy 
following the method outlined by Torres et al.
185
 It was found that the M and G fractions were 
0.61 and 0.39,respectively with a M/G ratio of 1.54, a value corresponding reasonably well with 
those previously reported for ALG produced by Macrocystis pyrifera.
186
 Although it has been 
shown that ALG with a high G content demonstrate a much higher in vivo stability
187
, ALGs 
with high mannuronic content were reported to show greater biocompatibility and 
recommended as suitable biomaterials for implants.
188
 To improve the mechanical properties of 
ALG, an internal gelation technique was selected since it allows formation of strong and 
homogeneous hydrogels despite a low G fraction. Draget et al.
189
 have developed as first a 
method to obtain uniform ALG hydrogel controlling the release of Ca
2+
 directly in the ALG 
solution. This slow gelation process leaded to a very homogeneous hydrogels with uniform pore 
size and distribution and consequent well-controlled material properties. Furthermore, the ALG-
calcium mixture can be poured into molds before gelation is complete and suitably shaped.  
 
3.2. Preparation and characterization of ALG and ALG/HA hydrogels  
Control over the material properties of a hydrogel is crucial for many biomedical 
applications. Structural uniformity is necessary not only for uniform drugs distribution, but also 
for consistently well-controlled material properties. Covalent crosslinking is an elective way to 
                                                     
 
 
185
 Torres M.R., Sousa A.P., Silva Filho E.A., Melo D.F. et al. Carbohydr Res. 2007 
186
 Moe S.T., Draget K.I., Skjåk-Bræk G., and Smidsrød O. Alginate in Food Polysaccharides and Their 
Applications. 1995 
187
 Kong H J, Alsberg E, Kaigler D, Lee K Y et al. Adv.Mater. 2004 
188
 Orive G., Ponce S., Hernandez R.M., Gascon A.R. et al. Biomaterials. 2002 
189
 Draget K.I., Ostgaard K. and Smidsrod O. Carbohydrate Polymers. 1990 
58 
 
 
stabilize three dimensional polymer networks for a variety of applications and has also been 
used in hydrogel formation with permanent 3-D structures. However, covalent crosslinking 
reagents are usually toxic and not suitable in biomedical application. In this work we have used 
CaCO3-GDL system to produce strong, uniform, transparent, and three-dimensionally defined 
ALG gels (Figure 1a). This method is based on the use of an inactivate form of calcium 
(CaCO3) that is mixed with alginate solution. The controlled release throughout the alginate 
solution of the crosslinking ion is usually obtained by means of a decrease of pH caused by the 
addiction of a slowly hydrolyzing molecule such as GDL. The use of CaCO3 and GDL in a 
molar ratio of 2 guarantees only slightly acidic pH in the final hydrogel.
190
 By adding a 
supplementary freeze-drying step, ALG-based sponges were obtained (Figure 1b). The presence 
of HA did not affect the macroscopic appearance of ALG/HA sponge. 
 
A)      B) 
 
 
Figure 17. ALG/HA 10 hydrogel (a) obtained by internal gelation and ALG/HA 10 sponge (b) obtained 
by internal gelation/freeze-drying. 
 
One of the aims of the present study was to formulate hydrogels which would remain 
intact after hydration and with sufficient strength to be removed from, wound bed. The 
hydrogels showed sufficient strength to be handled, cut with scissors or packed without 
difficulties.  
Gelation time is an important variable in hydrogel formulation, as previous studies have 
shown that a fast gelation time can lead to a poorly homogeneous gel structure.
191
 Gelation time 
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may depend on the availability of ALG chains for crosslinking with calcium ions, which can be 
impaired by the presence of HA in the medium.  
Gelation time was found to be dependent on the presence of HA in solution (figure 2) In 
fact gelation time increased with increasing HA content, which also progressively increased the 
viscosity of the medium. 
 
 
Figure 18. Gelation time and viscosity of ALG solution with or without HA. 
 
Viscosity increase could be directly related to the gelation time as the ALG chains having 
less free movement, due to the increased viscosity of the solution, interact with each other more 
slowly to form "egg box” structures. 
 
3.2.1. Hydrogel homogeneity 
Amid the large number of factors that can influence ALG gelation time
192
, concentration 
of calcium carbonate in the polymer solution is of utmost importance since it controls 
availability of calcium ions for crosslinking. On the other hand, calcium carbonate is dispersed 
in polymer medium and can progressively accumulate down of the recipient thus giving non-
homogeneous cross-linking. It is worth of note that structural uniformity is crucial for 
biomedical applications not only from a drug delivery viewpoint to achieve uniform distribution 
of the drug in the matrix, but especially to get good material properties. To evaluate the 
homogeneity of hydrogels made with CaCO3-GDL, cylindrical gels with varying compositions 
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were prepared and sliced along the vertical axis. Comparable homogeneity profiles of ALG gels 
at different HA concentrations indicated that the presence of HA did not significantly affect gel 
homogeneity in the concentration range studied (Figure 3). The slightly higher dry/wet weight 
ratio of the bottom slice was likely due to either adherence of the CaCO3 powder to the bottom 
during mixing or some sedimentation during gelation. 
 
 
 
Figure 19. Dry/wet weight ratios of ALG hydrogel slices with varying ALG/HA concentrations 
numbered 1-4, from top to bottom.  
 
3.2.2. Cross-linking degree 
The swelling behavior of ALG hydrogels is a function of crosslink density, ALG concentration, 
and ALG chemical composition.
193
 In particular, structural integrity and mechanical properties 
are highly dependent on crosslinking of G-blocks, that in presence of Ca
2+ 
form more highly 
ordered regions.
194
 During the internal gelation, Ca
2+
 is released directly inside the ALG 
solution, and for this reason its diffusion in the solution is essential to achieve a homogenous 
gelation. To determine whether hydrogels compositional variables should be considered for 
controlling swelling behavior as well, the effects of HA on swelling behavior were investigated. 
Swelling profiles were obtained for ALG and Alg/HA hydrogels immersed in medium with 
different Ca
2+
 concentrations for 7 days (figure 4). 
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Figure 20. Swelling behavior of ALG hydrogels immersed in medium of different Ca2+ for 7 days. 
 
It was found that all gels with or without HA gave a similar swelling behavior with a 
shrinking that directly depends from the calcium concentration in the medium. The W/W0 ratio 
was similar for all the formulation suggesting that the presence of HA had a minimum influence 
on the crosslinking degree. These results demonstrated also that cross-linking of G-rich ALG 
sequences was not complete. 
 
 
3.3.  Preparation and characterization of ALG and Alg/HA sponges 
3.3.1. Morphology and water retention 
ALG sponges, with or without HA, exhibit a macroporous and interconnected networks 
comprising numerous pores and channels. This highly porous structure is of utmost importance 
to ensure water absorption and mechanical strength, especially if an application as wound 
dressing is envisaged.  
The freeze drying method, which can prevent the destruction of the porous structure 
during the removal of water, was adopted in the preparation of crosslinked sponges starting 
from hydrogels obtained by internal gelation. To have sponges with good handling properties 
2% w/w alginate hydrogels were employed. The freezing method is useful to obtain regular pore 
sizes since the sponge porosity is directly correlated with the size of the ice crystal formed 
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during the freezing process.
195
 In particular Kang et al.
196
 showed that the sponge prepared at 
freezing temperatures near -20 °C, showed a three-dimensional structure with interconnected 
pore without the use of any additives and organic solvents.  
The Alg/HA sponges were imaged by SEM. The surface of ALG sponge exhibited a 
random highly porous structure from interconnected pores with size in the range of 100−300 
μm. Comparison of the ALG sponge (Fig. 5 A) and the ALG/HA sponges (Fig. 5 B-C) revealed 
that HA filled most of the sponge voids. 
 
  
 
Figure 21. SEM images of ALG (a) ALG/HA10 (b) and ALG/HA20 (c). Scale bar=1 mm. 
 
Water absorption (WA) and water retention (WR) are very important properties for 
sponge materials, which are highly dependent on their inherent structure and morphology. Main 
properties of Porosity (P), WA and WR values for the various ALG/HA sponges are 
summarized in Table 1.  
 
 
Table 7. Characteristics of ALG sponges. 
 
 Porosity (%) 
Density 
(mg/cm
3
) 
Water absorption 
(%) 
Water 
Retention 
(%) 
Equilibrium Water 
Content EWC (%) 
ALG 56.61 ± 1.03 30.76 ± 1.00 5103.95 ± 39.66 67.3 ± 1.8 98.14 ± 0.02 
ALG/HA10 72.27 ± 3.21 34.74 ± 1.05 4851.34 ± 63.77 78.8 ± 4.1 98.08 ± 0.09 
ALG/HA20 47.70 ± 3.11 34.59 ± 1.85 5070.04 ± 114.86 77.1 ± 2.4 98.09 ± 0.07 
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In comparison with ALG/HA, ALG crosslinked sponges, held more open and ordered 
pores as well as solid internal structure and exhibited the highest water absorption (>5100 g 
water per 100 g of solid sponge). Furthermore, the presence of HA influenced the sponge 
density, making them less porous. In Alg/HA sponges HA partially fills the gaps between the 
ALG chains, and this explain the reduction in porosity despite the constant pore diameters. The 
uniform and solid porous structure of crosslinked sponges should “lock” the water molecules 
and prevent the easy runoff of water. Comparing the water retention between neat ALG and 
ALG/HA sponges after the centrifugation treatment, WR of Alg/HA sponges was higher as 
compared to ALG sponge, this difference being limited. This may be attributed to the high 
hydrophilic character of hyaluronate
197
 that promote strong interactions with  water. 
 
 
3.3.2. Water uptake and degradation behavior of ALG/HA sponge 
The ability to absorb fluids is essential to envisage an use of these systems as advanced 
dressings. In fact high water absorption capacity is considered to be beneficial in application on 
highly suppurating wounds.
1
 Moreover, when the sponge incorporates a drug to deliver, drug 
release process is strictly related to water absorption kinetics, which are in turn affected from 
sponge physical structure. In order to clarify this point, water absorption kinetics of the various 
sponges were evaluated. Figure 6 shows water absorption capacity of sponges with different 
composition. 
  
Figure 22. Kinetics of water uptake of ALG and ALG/HA sponges. Results are reported as mean ± SD 
(n= 3). 
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Contrariwise to equilibrium water content, water absorption kinetics were influenced by 
the presence of HA in the sponge. The absorption curves of the ALG/HA hydrogels showed a 
higher rate of water uptake within the first 6h of immersion (equilibrium swelling) as compared 
with ALG sponges, while after 24 h all the formulations displayed the same water uptake. 
Differences in sponges porosity does not seem the main property to explain water uptake 
kinetics. Nevertheless, the high hydrophilic and polyanionic character of hyaluronate
198
 may 
lead to a such increase of the hydrostatic pressure within the sponge and promote its hydration 
rate. 
To get an insight into sponge behavior in a moist environment, the stability of ALG 
sponges in contact with a physiological fluid was investigated. The degradation time, and 
consequently the expected in vivo residence time, has been evaluated using a modified Enslin 
apparatus in which phosphate buffered saline (PBS) at pH 7.4 was employed as wetting 
medium. In the current study water uptake and stability were evaluated in an ionic solution 
which mimics the composition of blood plasma and synovial fluid with respect to inorganic 
ions. Since the calcium ion concentration in these solutions is too low to stabilize the hydrogels, 
slow degradation as a result of cross-linker ion loss is expected to occur. Sponges show 
completely different behaviors depending on the composition. in case of ALG sponge, its 
porous structure was maintained for three days while complete hydration was reached after 6 
days (Figure 23). A complete loss of structural integrity was reached in about 14 days.  
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Figure 23. Degradation kinetics of ALG sponge. 
 
Sponges containing HA, at both concentrations studied (Figure 24), show a different 
behavior. Indeed, Alg/HA sponges degrade more quickly than ALG sponge, reaching complete 
hydration in about 3 days, while the loss of structural integrity occurred after 7 days.  
 
 
 
Figure 24. Degradation kinetics of Alg/HA10 and Alg/HA20 sponge 
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The hydrophilic nature of HA is likely to affect also sponge degradation in vitro because 
it acts modifying both WA and WR. The consequent faster increase in ion exchange inside the 
sponge leads to disassembly of the egg box structure with a loss in structural properties. 
Furthermore, the Ca
2+
 diffusion throughout seems to be accelerate in presence of HA.
199
 
However, contribution of enzymatic degradation of HA operated by hyaluronidasis should be 
take into account. 
 
. 
 
3.3.3. Drug release from sponges 
The impact of matrix composition on drug release from loaded sponges was investigated. 
Sponges were loaded with TA, a drug with hemostatic properties, and its release followed to 
evaluate the ability of the system to reduce bleeding upon wound application. The ALG sponge 
showed the slowest release rate, whereas the presence of HA accelerated it (figure 25). The 
release of hydrophilic molecules from swellable sponges depends mainly from swelling 
kinetics, thus pointing to the presence of HA as a key parameter in affecting the release rate. 
Comparison between the release profiles of TA and water uptake curves highlight that the water 
uptake reached over 70% of its final value in 3 hours while in the same period almost 95% of 
TA is released. Thus, the swelling process reaches ends up in 6 hours, when all TA has been 
released. The incorporation of HA in the composite sponge significantly affected TA release 
profile because it causes a faster water absorption with a consequent larger burst effect. 
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Figure 25. Tranexamic acid release profile in PBS pH 7.4 
 
 
3.4.  In vitro toxicity: Effect of Alg/HA hydrogels on Ad-MSCs 
viability and motility.  
In order to evaluate the in vitro toxicity of hydrogels, human Mesenchymal Stem Cells 
(Ad-MSCs) previously isolated from subcutaneous adipose tissue biopsies were used.
200
 Cell 
viability was then investigated using a transwell system. The upper chamber was filled up with 
the hydrogel, while the lower chamber was loaded with a cell suspension in DMEM F12 (1:1), 
containing a 10% FBS. As shown in figure 26 sulforhodamine assay revealed that Ad-MSC 
viability in the presence of ALG and ALG/HA hydrogels was comparable to that achieved with 
DMEM F12 (1:1) 10% FBS.  
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Figure 26. Effect of ALG and ALG/HA hydrogels on Ad-MSCs viability. Ad-MSCs have been loaded at 
50,000 cells per insert in the lower chamber on a 0.4 μm pore polycarbonate membrane. The following 
day, ALG hydrogels or ALG-HA hydrogels (ALG/HA10% - ALG/HA20%) have been added in the upper 
chamber of the transwell in DMEM F12 (1:1) 10% FBS. Upon 24 hours, cell viability has been 
determined, as optical density, by sulforhodamine assay. The results have been reported as percentage of 
viable cells compared with cells incubated in DMEM F12 (1:1) 10 % FBS in absence of hydrogels 
(considered as 100% viable cells). Bars represent the mean ± standard deviation of triplicate 
determination in three independent experiments.  
 
 
Next, to investigate whether Alg/HA hydrogels could affect cell motility a wound healing 
assay was performed. Confluent monolayers of Ad-MSCs were scratched and incubated with 
ALG and ALG/HA hydrogels in medium without serum supplementation (DMEM F 12 -0.25% 
BSA). Images were taken at 0 and 24 h after wounding. As shown in figure 27, serum induced 
an almost complete wound closure. Even in absence of serum, ALG and Alg/HA hydrogels 
significantly promoted wound closure as compared to serum-free medium.  
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Figure 27. Effect of ALG and ALG/HA hydrogels on Ad-MSCs motility. Confluent monolayers of Ad-
MSCs, grown in DMEM F12 (1:1) 10% FBS, have been incubated with serum free medium (DMEM F12 
1:1 0.25% BSA) over night. The following day, cells have been subjected to scratch assays, washed twice 
with phosphate buffered saline (PBS) and incubated at 37°C in presence of ALG or ALG/HA 
(ALG/HA20%) hydrogels in DMEM F12 (1:1) 0.25% BSA. Images of wound gap have been taken at 0 
and 24 h by a digital camera coupled to the microscope and percentage of closure was calculated with 
NIH IMAGE J. The results have been reported as percentage of wound distance at 24 h compared with 
the starting point (time 0). Bars represent the mean ± standard deviation of triplicate determination in 
three independent experiments. Asterisks denote statistically significant differences respect to cells in 
DMEM F12 (1:1) 0.25% BSA (*p < 0.05; **p < 0.01; ***p < 0.001 ).  
 
 
Very interestingly, the stimulatory activity of HA on Ad-MSCs motility is evidenced also 
when it is included in the hydrogel. In fact, degradation of the hydrogels in the medium occurs 
and correspondent release of calcium ions and HA is realized. Thus, stimulatory effect on 
cellular proliferation exerted by HA and proteoglycan synthesis (particularly aggrecan) 
according to various mechanisms is likely to occur. It has been proven that HA induces protein 
kinase activity through CD44 receptor and activates a cytoplasmic signal transduction 
pathway.
201
 This pathway may include mitogen-activated protein activation, resulting in nuclear 
translocation of extracellular signal-regulated kinase 1 to stimulate cell proliferation.
202
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 Conclusions 
Hydrogels useful for wound treatment in form of hydrated and spongy-like sheets have 
been successfully produced. The internal gelation technique allow as to obtain strong 
tridimensional hydrogels with good handling characteristics. Presence of hyaluronan, whose 
seems to have a crucial role in wound healing, affected the alginate gelation time, but had a 
minimum influence on the crosslinking degree. In the case of sponge, hyaluronan increased 
hydrophilicity and porosity of the matrix with the consequent increased water uptake. These 
effects were demonstrated to modulated release rate of a hydrophilic drug incorporated in the 
sponge. Cellular studies highlight that hyaluronan incorporation in the alginate hydrogels 
promotes wound healing without any effect on cell viability. Taken together, these results 
demonstrate how integration of hyaluronan in a physically cross-linked alginate matrix can be a 
useful strategy to promote wound healing.  
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ALGINATE - HYALURONIC ACID HYBRID 
HYDROGELS FOR NANOSILVER DELIVERY TO 
INFECTED WOUNDS 
 
 
 Introduction 
Throughout the centuries a large number of traditional wound dressings were developed 
for wound healing, but only in 1962 the real revolution in wound care occurred when George D. 
Winter demonstrated that a moist environment can ensure a more rapid re-epithelialization as 
compared with the healing of the lesion left to dry.
203
 Nevertheless, moisture promotes the 
bacterial growth with consequent wound infections, which represents one of the main adverse 
effects that limit recovery of the diseased tissue.  
Silver has a long history as an antimicrobial agent
204,205
and has gained renewed interest in 
the wound-management industry as an effective antimicrobial agent due to increased antibiotic 
resistance. Several silver-containing wound dressings have been developed. Semi-solid 
preparations such as silver sulphadiazine cream
206
 and silver nitrate ointment
207
 are already used 
to treat bacterial infection since they remain on the surface of the wound for a longer period of 
time as compared with solutions. However for highly exuding wounds, semi-solid preparations 
are not very effective as they rapidly absorb fluid, lose their rheological characteristics and 
become mobile
208
. For this reason the use of solid wound dressings is preferred in case of 
exudative wounds as they are capable of a correct exudate management and persistence at 
wound site where they exert healing action.  
Nanosilver (NS) consists in clusters of silver molecules that range from 1 to 100 nm 
which have proven to be a highly effective form of silver with antimicrobial activity against 
bacteria, viruses and other eukaryotic micro-organisms.
209
 It’s simple synthesis and highly 
effective antibacterial activity make them a very attractive way to administer silver.
210,211
In 
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order to show any antimicrobial properties, silver has to be in its ionized form.
212,213
 In fact, 
silver in its non-ionized form is inert
214
, but in contact with moisture silver ions (Ag
+
) can be 
generated.
215
 In addition to its well-recognized antibacterial properties, NS can be used for 
modulate local and systemic inflammation and accelerate wound healing process
216,217
 due the 
capacity to reducing cytokine release
218
, decreasing lymphocyte and mast cell infiltration
219
 and 
inducing apoptosis in inflammatory cells.
220,221
 
Advanced dressings comprising both conventional barrier functions and bioactivity are 
designed to provide a fast and correct wound healing process. Novel wound dressings create a 
moist environment around the wound to facilitate wound healing and to maintain site hydration 
along time.
222
 Through the years a number of modern dressings have been developed as an 
advance upon the traditional wound healing agents, and their use on different wound types 
found to be highly dependent on the material employed.
223
 Among the materials already used in 
commercial wound dressing, sodium alginate (a water-soluble polysaccharide extracted from 
brown seaweed) is considered one of the most versatile. Alginates (Alg) can be easily cross-
linked through divalent ions such as Ca
2+
 and Zn
2+
 forming hydrogels with improved 
mechanical properties. Since Alg are highly absorbent, Alg-based dressings can fit application 
on highly exuding wounds where microbial infections are common. Furthermore Ca
2+
 cross-
linked Alg dressings show biological function due to the presence of calcium ions that 
orchestrate some cellular events of wound healing.
224,225
 Nevertheless release of calcium from 
cross-linked Alg dressings plays a physiological role aiding the clotting mechanism 
(hemostasis) during the first stage of wound healing.
226,227
By incorporating silver ions into Alg 
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fibers, it is expected that a highly absorbent wound dressing with good antimicrobial properties 
can be obtained. 
Hyaluronan or hyaluronic acid (HA) is a long-chain polysaccharide that is found naturally 
in the body and acts both as a structural component of the extracellular matrix (ECM) and as a 
mediator of various cellular functions. Several studies indicates that HA is involved in each 
phase of wound healing
228
 and one of his function is the modulation of inflammatory cell and 
dermal fibroblast activities.
229,230,231
 HA functions during wound formation of a porous networks 
during inflammation and as a space filler in granulation tissue. In contrast, short HA fragments 
have stimulatory and attracting properties toward fibroblasts and stimulate collagen 
production.
232
 Furthermore, different HA lengths stimulate the production of specific collagen 
types, which can promote or inhibit scar formation.
233
 Since HA is found in the ECM 
throughout the body, biomaterials based on HA derivatives show promising properties for 
clinical application and can be taken into consideration to promote tissue repair and wound 
healing.
234
  
The aim of this work is to develop a NS-cloaded Alg dressing able to accelerate tissue 
repair and to control bacterial infection. To this purpose, we propose a Ca
++
 cross-linked Alg 
dressing containing dispersed HA of medium molecular weight to help repair and releasing 
silver ions in the wound bed. Biological behavior of the hydrogels were studied on human 
Adipose Mesenchymal Stem Cells and in a rat model of wound healing to evaluate their toxicity 
and wound repair potential. Finally, NS-loaded hydrogels were tested on clinical isolates from 
infected wounds to evaluate antimicrobial activity.  
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 Materials and methods 
 
6.1. Materials  
Pharmaceutical grade sodium alginate (Alg) extracted from Laminaria hyperborea 
(viscosity 360 cps) was purchased from Farmalabor (Italy). Analysis-grade ethanol was 
purchased from Carlo Erba (Italy). Calcium carbonate (CaCO3), D-glucono-δ-lactone (GDL), 
sodium chloride (NaCl), potassium chloride (KCl), sodium phosphate dibasic (Na2HPO4) and 
hyaluronic acid sodium salt from Streptococcus equi (1.5-1.8 * 10
6
 Da) were obtained from 
Sigma-Aldrich (USA). Colloidal silver solution (NS) was provided from Cluster nanotech s.r.l. 
Media, sera, and antibiotics for cell cultures were from Lonza (Lonza Group Ltd, Basel, 
Switzerland). Depurated and filtered (Milli Q filter) water was used throughout this study.  
Male Wistar albino rats weighing 300-350 g were purchased from Harlan-Italia (San 
Pietro al Natisone, UD). All the rats were housed singly, to prevent fighting and attack on the 
wounds, for one week in Plexiglas cage at temperature of 22 ± 1 °C, with alternate cycle of 12 
hours of light and 12 hours of dark. All animals received food and water ad libitum throughout 
the experimental period. All manipulations were performed using aseptic techniques. This study 
was carried out in strict accordance with the Institutional Guidelines and complied with the 
Italian D.L. no.116 of January 27, 1992 of Ministero della Salute and associated guidelines in 
the European Communities Council Directive of November 24, 1986 (86/609/ECC).  
 
6.2. NS characterization 
NS was characterized to evaluate size and shape. The size was obtained from dynamic 
light scattering using a Zetasizer Nano ZS (Malvern instruments, UK). Particle size and 
polydispersity were registered at a scattering angle of 90◦and at a temperature of 25°C. 
NS morphology was visualized by Transmission Electron Microscopy (TEM) Sample for 
TEM analysis was prepared by placing one drop of NS onto a copper grid. After approximately 
1 hour images were captured by a transmission electron microscope. TEM analysis was 
performed with a FEI Tecnai G12 (LAB6 source) equipped with a FEI Eagle 4 K CCD camera 
(Eindhoven, The Netherlands) operating with an acceleration voltage of 120 kV. 
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6.3. Hydrogel preparation 
Structurally homogeneous calcium Alg hydrogels were made as previously described by 
Kuo and Ma.
235
 Briefly Alg was dissolved in deionized water (1% w/v) and mixed together with 
calcium carbonate (CaCO3) 30mM to form a suspension. A fresh aqueous 64 mM GDL solution 
was then added to the suspension and vortex mixed to initiate gelation. A CaCO3 to GDL molar 
ratio of 0.5 was maintained to achieve a neutral pH post-crosslinking. The HA was dissolved 
directly in the Alg solution to obtain the concentrations of 10% and 20% w/w. The different 
solution were cast in 96 well plate (50 µl, well size: 5 mm diameter, 20 mm height) to form 
circular discs 2 mm in thickness and 5 mm in diameter or in a 24-well plate (1 ml, well size: 15 
mm diameter, 20 mm height) to form circular discs 5 mm in thickness and 15 mm in diameter, 
depending on use. The well plate were capped, sealed with Parafilm
®
, and gelled on a leveled 
plate at room temperature for 24 h. Different concentrations of nanosilver were added to Alg 
solution before gelation to obtain nanosilver-loaded gels. After gelation the Alg hydrogels were 
washed with water and stored at 4°C until use.  
 
Table 8. Hydrogel compositions tested in the study. 
 
 
Alginate (% w/v) HA (% w/w) NS 
ALG 1 % - - 
ALG/NS10 1% - 10 ppm 
ALG/NS50 1% - 50 ppm 
ALG/NS10/HA10 1 % 10 % 10 ppm 
ALG/NS50/HA10 1 % 10 % 50 ppm 
ALG/NS10/HA20 1 % 20 % 10 ppm 
ALG/NS50/HA20 1 % 20 % 50 ppm 
 
 
 
6.4. Hydrogel characterization 
Water uptake was determined by placing the cross-linked hydrogels in water. The initial 
weight of three circular samples (15 mm diameter) was measured by using an analytical 
balance. The samples were then placed in 5 mL of water at 37 °C in a thermostatic bath. 
Samples were taken out and excess water was removed by gentle blotting with tissue paper. 
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Samples were weighed and then placed again in 5 mL of water at 37 °C. The weight of the 
samples was recorded at regular intervals until no weight change was recorded was established. 
Results are expressed as swelling ratio percent (SR %) at each time point according the 
equation: 
 
SR ( )   
W W0
W0
   100 
 
where W is the mass of the swollen sample and W0 is the mass of the initial dry sample. 
The equilibrium water content (EWC) per cent was calculated by the equation: 
 WC (%)  
We   Wd
We
  100 
 
where We is the mass of the swollen sample at equilibrium and Wd is the mass of the dry 
sample at equilibrium. 
Changes of hydrogel aspect along time upon contact with a medium simulating biological 
fluids in tissue injuries were registered.
236
 Hydrogels were placed in contact with a Phosphate 
Buffer Saline (PBS, NaCl 120 mM, KCl 2.7 mM, Na2HPO4 10 mM) at pH 7.4 (Ph.Eur 8) by 
means of a modified Enslin apparatus. Pictures of the hydrogels are taken over time. Three 
replicates were performed for each sample. 
 
 
6.5. Cell culture studies 
6.5.1. Cell lines  
Adipose Mesenchymal Stem Cell (Ad-MSC) were isolated as previously reported
237
 from 
human adipose tissue biopsies through digestion with collagenase. Ad-MSC were cultured at 
37°C with Dulbecco's modified Eagle's medium (DMEM) and Ham's F12 (1:1) with 10% FBS, 
2 mM glutamine, 100 IU/ml penicillin, and 100 IU/ml streptomycin. Cultures were maintained 
in humidified atmosphere of 95% air and 5% CO2 at 37° C.  
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6.5.2. Cell viability 
Ad-MSC viability was assessed by sulforhodamine assay.
238
 Briefly, Ad-MSCs (5,000 
cells/well) were seeded in 96-well culture plates in a complete medium. The following day the 
cells were incubated with raising concentrations of silver nanoparticles (NS). Upon for 24h, the 
cells were fixed with 50% trichloroacetic acid for 2 h at 4 C. Then, cells were washed 5 times 
with distilled and de-ionized water. After air drying, cells were stained for 30 min with 100 μl 
0.4% sulforhodamine dissolved in 1% acetic acid. Unbound dye was removed by five washes 
with 1% acetic acid. After air drying, 10 mM Tris solution (pH 7.5) was added to dissolve the 
protein-bound dye. Cell survival was assessed by optical density (OD) determination at 510 nm 
using a microplate reader.  
To investigate the effect of Alg hydrogels on Ad-MSC viability, 50,000 cells were seeded 
in the lower chamber of a 24-transwell culture system (0.4-μm pore polycarbonate membranes; 
Costar, Cambridge, MA). The following day, the hydrogels were added to the upper chamber in 
complete medium. Upon 24h, sulforhodamine assay was performed. Three replicate wells were 
used for each data point, and the experiment was performed three times.  
 
6.5.3. Cell motility- Wound healing Assay 
Ad-MSCs were seeded into six-well microplates and grown in a complete medium to a 
confluent monolayer. Then, the cells were wounded by manually scratching with a p20 pipette 
tip. Reference points near the “scratch” were marked to guarantee the same area of image 
acquisition. The wells were washed twice with phosphate buffered saline (PBS) and incubated 
at 37 C with hydrogels. Images of wound gap were taken at 0 and 24 h by a digital camera 
coupled to the microscope and percentage of closure was calculated with NIH IMAGE J. These 
experiments were repeated at least three times. 
 
 
6.6. Antibacterial activity on clinical isolates  
The antibacterial activity of the ALG/NS or ALG/NS/HA hydrogels was evaluated by the 
Luria-Bertani agar plate method against clinical isolates of both Gram-positive (methicillin-
resistant Staphylococcus aureus, Staphylococcus epidermidis) and Gram-negative (multidrug 
resistant Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumanni , Klebsiella 
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pneumoniae) bacterial strains, obtained from the Diagnostic Unit of Bacteriology and Micology 
of the University Federico II of Naples. The bacterial isolate were grown under aerobic 
conditions in Brain-heart infusion broth (Becton Dickinson) at 37°C until to mid-log phase. The 
inoculum of each bacterial strain was adjusted to 10
5
 colony-forming units (CFU)/ml and 1 ml 
incubated in the presence of the hydrogels or Alg solution for 24 h or 48 h at 37°C. Three 
concentration (2, 10 and 50 ppm) of silver solution and two concentrations (10 and 50 ppm) of 
Alg/NS or Alg/NS/HA hydrogels were used. Each assay was performed in triplicate. After 
incubation period, a viability count was performed by dilution and plating on LB agar and 
incubation at 37°C for 24 h. The viable cells were counted by quantization of CFUs and 
expressed as mean and standard deviation of three assays.  
 
 
6.7. In vivo wound healing studies 
A full-thickness excision wound model was used to monitor wound closure. All the 
animals were anesthetized with ketamine hydrochloride (100 mg/kg body weight) and xylazine 
(5 mg/Kg) by intraperitoneal administration, and the dorsal hair was shaved using a shaving 
machine. The surgical area was disinfected with Betadine R 10%. A full-thickness wound with 
a diameter of 2,5 cm was excised from the back of the rats using sterile scissors at the depth of 
loose subcutaneous tissues and the wounds were left open. Hemostasis was obtained by direct 
pressure using a sterile gauze. Before hydrogel application the wound was moistened with 300 
μL of saline solution. Animals (n 3) were divided into four groups and wounds were treated 
with a single application of unloaded hydrogels (Alg, Alg/HA20) or NS-loaded hydrogels 
(Alg/NS, Alg/NS50/HA20) containing 50 ppm NS.. On top of the wounds, a piece of 
Tegaderm
TM
 (3M, USA) was applied to prevent the rats from removing the treatments. For 
wound closure study, changes in wound area were measured on day 1 and 5 and wound closure 
was calculated according to Equation: 
 
               
      
  
      
 
Where A0 is the initial wound area and At is the open area of wound at day 1 and 5 after biopsy.  
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6.8. Statistical analyses 
Statistical analyses were undertaken using GraphPad Prism®, version 4.00 (GraphPad 
Software, San Diego, USA). Data were compared using a Student's t-test, a one-way ANOVA, 
with a Bonferroni post-test (parametric methods). 
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 Results and discussion  
7.1. Nanosilver containing hydrogels  
NS employed in our studies have a mean diameters of 0.8 nm. A low PI (0.110) indicates 
good size homogenity of NS solution (figure 28). 
 
Figure 28: Size analysis of NS 
 
 
TEM images show that Ag NPs are less than 1 nm, in agreement with DLS, and 
characterized by spherical shape (data not shown). 
The bactericidal effects of NS depends directly from the particle size, since smaller 
particles induce a stronger inhibition of microorganism growth with respect to larger ones. 
Morones et al.
239
 found that NS in the range of 1-10 nm are attached the cell membrane with 
more affinity as compared with larger nanoparticles, drastically perturbing the membrane 
function with consequent cellular death.  
 
Solid transparent ionically cross-linked Alg/HA hydrogels or Alg/NS/HA sheets with 
different compositions were prepared (Table x) using the internal gelation technique. This 
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method, which is characterized by a slow release of Ca
2+
 ions directly from the inside the Alg 
solution, allow as to obtain homogeneous hydrogels which have sufficient strength to be 
handled, cut with scissors or packed without difficulties.
240
,
241
,
242
 Visually, hydrogels Alg and 
Alg/HA have a homogeneous aspect and the presence of NS does not have any effects on 
hydrogels physical properties. The physical characterization of this system gave results close to 
those reported in chapter X.  
The ability to absorb fluids is essential for using hydrogels as advanced dressings and 
water absorption capacity is considered to be beneficial in application on suppurating wounds 
{Boateng, 2008 635 /id}. A silver-containing hydrogel acts by absorbing exudates and releasing 
the silver onto the wound bed, killing microorganisms both in the wound and within dressings. 
Xiu et al.
243
 demonstrated that the antibacterial activities of NS is entirely due to the release of 
Ag
+
 ions in the medium rather than to NS themselves. To evaluate the absorption rate, ionically 
cross-linked ALG and ALG/HA hydrogels were placed in water and the swelling ratio (SR%) 
was measured in terms of mass increase at regular time intervals (figure 29).  
 
 
 
 
 
Figure 29. Water uptake of Alg hydrogels. 
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When comparing the weight change behavior of each hydrogel, it is clear that the 
hydrogel of Alg has a higher swelling ratio than Alg/HA hydrogels. The absorption curves of 
the Alg/HA hydrogels showed a similar water absorption rate within the first 3 h of immersion, 
while after this point the higher swelling of Alg hydrogel allows to absorb a greater amount of 
water. The fastest water uptake is probably due to the high hydrophilic and polyanionic 
character of hyaluronan
244
 that may lead to an increase of the hydrostatic pressure within the 
hydrogels and promote its hydration rate. 
Hydrogel stability along times upon contact with a simulated physiological fluid was 
examined. The degradation time, and consequently the in vivo residence time, has been 
evaluated using a modified Enslin apparatus in which the wetting liquid, a phosphate buffered 
saline (PBS) at pH 7.4, is in contact with one side of the hydrogel. The extent of degradation 
changed depending on the composition of the hydrogel, being in the order Alg/HA20 > 
Alg/HA10 > Alg (Figure 30 and 31). The degradation mechanism for the crosslinked hydrogels, 
and the consequent loss of structural integrity in time, is correlated to hydrolysis of the 
glycosidic bonds and the Na
+
 ions (present in PBS) interchange with cross-linking Ca
2+
 ions.
245
  
 
 
 
Figure 30. Degradation kinetics of ALG hydrogel. 
                                                     
 
 
244
 {Toole, 2004 40 /id} 
245
 {Lee, 2012 660 /id} 
84 
 
 
-  
 
Figure 31. Degradation kinetics of Alg/HA10 and Alg/HA20 hydrogels. 
 
 
The difference in degradation rate between the hydrogel ALG/HA and Alg is greater at 3 
days than at 1 days. This phenomenon can be explained by the fact that the ALG/HA polymeric 
matrix is less cross-linked due to the presence of HA chains that hampers ionic interaction 
between Alg and Ca
2+
 ions.
246
 The hydrophilic nature of HA
247
 increased the degradability of 
the hydrogels likely due to a faster water absorption and a consequent faster exchange of Ca
2+
 
ions with Na
+
 and K
+
 ions.  
 
7.2. Effect of nanosilver (NS) and Alg/NS hydrogels on Ad-MSC 
viability 
In order to evaluate NS and Alg/NS hydrogels toxicity on a cellular model, we employed 
human Mesenchymal Stem Cells (Ad-MSCs) previously isolated from subcutaneous adipose 
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tissue biopsies.
248
 As assessed by sulforhodamine assay, 10 and 50 ppm NS did not interfere 
with cell viability (fig.x). At variance, higher concentrations of NS (70, 100, 150 ppm) 
significantly reduced Ad-MSC viability (figure 32). 
 
 
 
Figure 32. Effect of NS on Ad-MSCs viability. Ad-MSCs (5,000 cells/well) have been seeded in 96-well 
culture plates in DMEM F12 (1:1) 10% FBS. The following day the cells have been incubated with 10, 
50, 70, 100 or 150 ppm silver nanoparticles (NS). Upon 24 hours, cell viability has been determined, as 
optical density, by sulforhodamine assay. The results have been reported as percentage of viable cells 
compared with cells incubated in DMEM F12 (1:1) 10 % FBS in the absence of NS, considered as 100% 
viable cells. Bars represent the mean ± standard deviation of triplicate determination in three independent 
experiments.  
 
 
 
Then, we investigated the effect of Alg/NS hydrogels on cell viability using a transwell 
system. The upper chamber was filled up with Alg hydrogels, while the lower chamber was 
loaded with cell suspension in complete medium. As shown in figure 33, sulforhodamine assay 
revealed that Ad-MSC viability in the presence of Alg and Alg/HA hydrogels (at both HA 
concentration used) was comparable to that achieved with DMEM F12 (1:1) 10% FBS. The 
same test was performed on hydrogels loaded with 10 ppm of NS and also in this case the 
results indicated that the NS-loaded systems produced did not impair cell viability (fig. y). 
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Figure 33. Effect of NS loaded Alg hydrogels on Ad-MSCs viability. Ad-MSCs have been loaded at 
50,000 cells per insert in the lower chamber of a 24-transwell culture system (0.4μm pore polycarbonate 
membrane). The following day, Alg hydrogels (ALG), ALG/NS hydrogels, ALG/HA hydrogels 
(ALG/10% HA- ALG/ 20% HA) or ALG/NS/HA 10%-20% hydrogels, have been added in the upper 
chamber of the transwell in DMEM F12 (1:1) 10% FBS. Upon 24 hours, cell viability has been 
determined, as optical density, by sulforhodamine assay. The results have been reported as percentage of 
viable cells compared with cells incubated in DMEM F12 (1:1) 10 % FBS in absence of hydrogels, 
considered as 100% viable cells. Bars represent the mean ± standard deviation of triplicate determination 
in three independent experiments.  
 
 
7.3. Effect of nanosilver (NS) and Alg/NS hydrogels on Ad-MSC 
motility 
Next, to investigate whether NS and Alg/NS hydrogels could affect cell motility, a wound 
healing assay was performed. Confluent monolayers of Ad-MSCs were scratched and incubated 
with 10 ppm of NS and NS-loaded hydrogels in medium without serum supplementation 
(DMEM F 12 -0.25% BSA). Images were taken at 0 and 24 h after wounding. As shown in fig. 
z, serum induced an almost complete wound closure. Even in the absence of serum, NS, Alg 
and Alg/NS significantly promoted wound closure compared to serum free medium (figure 34). 
Very Interestingly Alg/HA20 induced a higher extent of wound closure which was only partly 
reduced by NS incorporation (figure 34). Thus, NS and ALG/NS hydrogels did not interfere 
with cell viability, but improved cell motility depending on the presence of NS and HA. 
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Figure 34. Effect of NS and Alg/NS hydrogels  on Ad-MSCs motility. Confluent monolayers of Ad-
MSCs, grown in DMEM F12 (1:1) 10% FBS, have been incubated with serum free medium (DMEM F12 
1:1 0.25% BSA) over night. The following day, the cells have been subjected to scratch assays, washed 
twice with phosphate buffered saline (PBS) and incubated at 37°C in presence of 10 ppm NS, Alg 
hydrogels (ALG), ALG/NS hydrogels, ALG/NS/HA20 hydrogels in DMEM F12 (1:1) 0.25% BSA. 
Images of wound gap have been taken at 0 and 24 h by a digital camera coupled to the microscope and 
percentage of closure was calculated with NIH IMAGE J. The results have been reported as percentage of 
wound distance at 24h compared with the starting point (time 0). Bars represent the mean ± standard 
deviation of triplicate determination in three independent experiments. Asterisks denote statistically 
significant differences respect to cells in DMEM F12 (1:1) 0.25% BSA (*p < 0.05; **p < 0.01; ***p < 
0.001 ).  
 
 
7.4. Antimicrobial activity 
The antibacterial activity of NS at 2, 10 and 50 ppm indicated as NS2, NS10 and NS50, 
respectively was tested to search for the minimal bactericidal concentration [MBC] to be used in 
subsequent tests with NS-loaded hydrogels. At all NS concentrations strong antibacterial effects 
against P. aeruginosa, E. coli, S. aureus and S. epidermidis at 24 h were observed, whereas only 
NS10 and NS50 resulted active against the same bacterial strains at 48 h (figure 35). Therefore, 
the higher concentrations were used in all subsequent experiments with hydrogels. 
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Figure 35. Colony forming units (CFU)/ml of viable bacteria after 24h and 48h incubation with different 
ppm of silver solution. Significant differences (P values < 0.05) in CFU/ml in comparison to control are 
indicated with asterisks. Data are shown as means of three independent experiments with SD indicated by 
the error bar. 
 
 
Figure 36 (A) shows the antibacterial effects of Alg/NS and Alg/NS/HA20 hydrogels on 
Gram-positive bacteria. Both 10 and 50 ppm ALG/NS/HA20 hydrogels showed bactericidal 
activity against S. aureus after 24 h incubation, whereas hydrogels were ineffective at 48 h. 
Alg/NS and Alg/NS/HA20 hydrogels significantly reduced the viable counts of S. epidermidis 
after 24 h of treatment with all the concentrations tested, but only Alg/NS50 and 
ALG/NS50/HA20 hydrogels were bactericidal at 48 h. 
Figure 36 (B and C) shows the antimicrobial activity of Alg/NS and Alg/NS/HA20 
hydrogels on Gram-negative strains. At both 10 and 50 ppm, NS-loaded  Alg and Alg/HA20 
hydrogels showed bactericidal effects on P. aeruginosa, A. baumannii, K. pneumoniae after 24 
h treatment; the total number of E. coli cells was significantly reduced after 24 h incubation at 
both NS concentrations, but only ALG/NS50/HA20 hydrogel showed antibacterial activity in 
comparison to the control. After 48h treatment, ALG/NS and ALG/NS/HA hydrogels were 
ineffective; only the A. baumannii  viable cells were significantly reduced by 50 ppm NS-loaded 
ALG hydrogel. 
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Figure 36. Colony forming units (CFU)/ml of viable bacteria (A: S. aureus and S. epidermidis; B: E. coli 
and P. aeruginosa; C: A. baumannii and K. pneumoniae) after 24h and 48h incubation with different ppm 
of silver solution and ALG/NS/HA and ALG/NS hydrogels. Significant differences (P values < 0.05) in 
CFU/ml in comparison to control are indicated with asterisks. Data are shown as means of three 
independent experiments with SD indicated by the error bar. 
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There are two possible explanations to why gram-positive bacteria are less susceptible to 
Ag
+
 than gram-negative bacteria. The first involves the charge of peptidoglycan molecules in 
the bacterial cell wall. Indeed, gram-positive bacteria have more peptidoglycan than gram-
negative bacteria because of their thicker cell wall, and because peptidoglycan is negatively 
charged and silver ions are positively charged, more silver may get trapped by peptidoglycan in 
gram-positive bacteria than in gram-negative bacteria. 
249
The decreased susceptibility of gram-
positive bacteria can also simply be explained by the fact that the cell wall of gram-positive 
bacteria is thicker than that of gram-negative bacteria. 
 
 
7.5. Wound healing effect of Alg/NS hybrid hydrogels 
Evaluation of wound healing process induced by hydrogels was evaluated by the excision 
wound model in rats (figure 37). 
 
 
Figure 37. Macroscopic appearances of skin wounds treated with different Hydrogels at day 0 and 14 in 
excision wound model. 
 
 
Wound closure is reported for each group as percentage of the reduction in wounded area 
at day 0, 1, and 5 (Figure 38).  
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Figure 38. Effects of Alg hydrogels on wound healing process in a rat model. *P<0.05; **P<0.01; 
***P<0.001 vs ALG. 
 
All experimental groups began to show reductions in open wound area from day 1 
(Figure 38). By day 5, the wound area reductions observed for Alg/NS50/HA20 hydrogel were 
significantly greater than with the untreated control group. As compared to the Alg treated 
group, Alg/NS50 had no significant effect on wound area reduction at day 1, while the 
formulation containing HA significantly reduced wound area. After 5 days all the tested 
formulations have a significant action on wound healing, with Alg/HA20 and Alg/NS50/HA20 
hydrogels showing the morst pronounced effect. 
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 Conclusions 
Silver is used from many centuries as antimicrobial agent in wound healing, but recently 
new studies highlighted his influence on wound healing. The bactericidal mechanisms of silver 
nanoparticles (NSs) were intensively studied and experimental evidence show that a very small 
particle size is important for the antimicrobial effects. In this work NS was dispersed in an 
alginate hydrogel to obtain an biomedical device with a direct action on wound healing. The 
internal gelation technique allow as to obtain strong tridimensional hydrogels with good 
handling characteristics. Moreover, the adding of hyaluronic acid, a natural polysaccharide 
whose seems to have a crucial role in wound repair, was investigated to enhance the wound 
healing effects. The presence of hyaluronic acid is directly correlated to hydrogels physical 
properties while NS don’t interfere with them. Alg/NS/HA hydrogels seem to have a strong 
antimicrobial activities against gram+ and gram- bacteria without any effect on cell viability. In 
vitro tests showed that Alg/NS/HA composite hydrogels can improve cell motility depending on 
the presence of NS and HA. In the in vivo experiments, Alg/NS/HA composite exhibited good 
wound healing activity in full-thickness excision wound model in rats. Overall, our results 
suggested that combination of bioactivity of hyaluronic acid and the antimicrobic activities of 
NS promoted tissue reconstruction processes, indicating that Alg/NS/HA hydrogels are a 
potential wound dressing for cutaneous wound healing. 
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IN SITU FORMING ALGINATE HYDROGELS 
CONTAINING A TEA TREE OIL NANOEMULSION 
FOR WOUND HEALING 
 
 
1 Introduction  
From centuries wound dressings are used to protect the surface of the wound from 
microbial contamination. Even though wound dressings such as plasters and bandages can 
protect the wound, they may also cause sufferings and pains to the patient during the dressing 
and removal processes.  
Alginates (Alg) are generally referred to as a family of polyanionic copolymers derived 
from marine kelp, mainly the brown sea algae
250
, and are of growing importance in the 
healthcare and pharmaceutical industry.
251
 The various applications of Alg gels have exploited 
the wide range of gelling approaches, physical properties, cell adhesion, and degradation 
behaviour of this family of materials.
252
 The ability of Alg to form crosslinks in presence of 
divalent ions has permitted the development of biocompatible hydrogels that helps to maintain 
the lesion at an optimum moisture content and healing temperature.
253
 Sodium Alg, in 
combination with other biopolymers or active agents, is widely used as film dressings to 
improve wound healing and prevention of burns infection in human.
254,255
  
Hydrogels are a network of polymers filled with water that may be applied to absorb 
wound exudates and protect wounds from secondary infection. Furthermore, hydrogels can be 
readily removed from the wound site by washing with water. An in situ–forming hydrogel (ISG) 
is initially fluid at room temperature but becomes a fixed gel in situ due to specific conditions, 
including ionic cross-linking, pH, and temperature change.
256
 ISGs have some merits over 
traditional dressings, including conformability without wrinkling or fluting of the wound bed, 
ease of application, good patient compliance, and comfort. With these characteristics, ISGs are 
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the optimal choice to prepare a multifunctional wound dressing. Polysaccharide ISGs obtained 
by simultaneous and alternate spraying of polyanions and polycations (layer-by-layer, LbL) are 
gaining in interest because they allow to quickly obtain highly uniform thin film over a large 
surface area.
257,258
 The alternate polysaccharide deposition on a solid substrate represents an 
appealing option to applicate ISGs, because it is much faster and easier to adapt at an industrial 
level.
259
 This type of systems can deliver preferentially hydrophilic molecules inside wound 
bed.  
Tea tree oil (TTO) is a natural essential oil steam-distilled from the Australian native 
plant Melaleuca alternifolia. TTO natural composition is well-characterized by approximately 
100 constituents, the majority being monoterpene and sesquiterpene hydrocarbons and their 
alcohols.
260
 TTO is a very promising agent for the treatment of dermatologic disease due his 
antimicrobial effects against a wide spectrum of microorganisms
261,262
 and minimal impact on 
developing resistance.
263
 TTO also has potent activity against many fungi,
264,265
 protozoa,
266,267
 
and certain viruses, including herpes simplex and influenza viruses.
268,269
 Besides the well-
known antimicrobial activities, TTO has been shown to possess a number of other therapeutic 
properties, including anti-inflammatory activities 
270,271,272
 and anti-tumor properties,
273
 
especially in the skin cancer.
274,275
 Hydrogels containing TTO were already tested in burn 
wound model and seams increasing the rate of wound healing.
276
 The physical characteristics of 
TTO present certain difficulties for the formulation of essential oils based products, thus 
limiting applicability. In particular their lipophilicity leads to miscibility problems in water-
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based products, while its volatility means that the encapsulation method must provide an 
adequate barrier to volatilization.  
Nanoemulsions (NE) are of great interest in drug delivery, as they represent a convenient 
way to encapsulate hydrophobic drugs, and have emerged as novel vehicles for sustained or 
controlled release for many administration routes of drugs.
277
 NEs appears as an attractive and 
competitive system due to many benefits such as easy manufacturing, small droplet size 
(20−200 nm), high thermodynamic stability, and enhanced solubilisation for hydrophobic 
ingredients. In recent years, nanoemulsions have been investigated as potential drug delivery 
vehicles for transdermal and dermal delivery of many compounds especially hydrophobic 
compounds in order to avoid clinical adverse effects associated with oral delivery of the same 
compound.
278
 Furthermore, nanoemulsion droplets can be easily incorporated into Alg 
hydrogels to create composite hydrogels with a controlled release profile.
279
 Nanoencapsulation 
can represent a viable and efficient approach to increasing physical stability of essential oil, 
protecting them from undesired interaction and increasing their bioactivity. In particular Donsi 
et al.
280,281
 demonstrated that NEs can enhances the antimicrobial activity of encapsulated 
essential oil increasing their water solubility and the consequent capacity to interact with cell 
membranes. 
The objective of the study was to develop antimicrobial in situ-forming Alg wound 
dressings incorporating TTO. Alg hydrogels were prepared by a layer-by-layer sparay 
deposition method with the aim to minimize the discomforts especially during dressing 
application. After characterization of TTO NE and TTO NE-loaded Alg hydrogels, their 
antimicrobial effect was tested.  
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2 Experimental 
2.1 Materials 
 Pharmaceutical grade sodium Alg acid sodium salt (Alg) extracted from Laminaria 
hyperborea (viscosity 360 cps) and Tea Tree Oil (TTO) were supplied by Farmalabor (Italy). 
Polysorbate 80 (Tween
®
 80), calcium chloride dihydrate (CaCl2 * 2H2O), sodium chloride 
(NaCl), potassium chloride (KCl), sodium phosphate dibasic (Na2HPO4), and nile red (NR) 
were obtained from Sigma-Aldrich (USA). Analysis-grade ethanol was provided by Carlo Erba 
reagenti (Italy). The spray pump used for the spray deposition (Classic line equipped with SL 
pump) was kindly gifted by Aptar Pharma (France). The water used throughout this study was 
depurated and filtered (Milli Q filter).  
 
2.2 Pseudoternary Phase Diagrams 
The boundaries of the NE domains were determined, with the aid of pseudo ternary phase 
diagrams for the polysorbate 80:ethanol, TTO and water systems, at different 
ethanol:polysorbate 80 volume ratios. A titration method was employed for the construction of 
phase diagrams. Different mixtures of polysorbate 80 and ethanol (1:1, 2:1 and 3:1) were 
weighed in a dark-brown, screw-cap glass vial, mixed using a magnetic bar on a stirring plate 
for 1 h and subsequently stored overnight at room temperature. TTO was then added at ratios 
ranging from 9:1 to 1:9 to different vials. Finally, aqueous phase was slowly added (under 
vigorous stirring) with a graduated syringe up to clouding of homogenous mixture of oil and 
surfactants:co-surfactants. Approximately 10 data points were obtained to determine each 
pseudoternary phase diagram. No attempts were made to completely identify the other regions 
of the phase diagrams in detail, and these have been described in terms of their visual and 
external appearance. To graphically show the phase variations of polysorbate:ethanol–water–
TTO system a pseudo-ternary phase diagram was built using Microsoft excel software. 
 
2.3 Preparation of nanoemulsion 
Once the nanoemulsion region was identified, a surfactant/co-surfactant mixture was 
prepared and dissolved in TTO using a magnetic stirring plate. An oil-in-water NE was prepared 
by slowly adding water to the oil phase (oil plus surfactants) under continue magnetic stirring. 
To prepare the NR-loaded NE, the probe was dissolved directly into TTO at the concentration of 
20 µg/ml. All the formulations were prepared at room temperature and tested after 24 h, the 
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time necessary for allowing equilibrium. Resulting mixtures were visually inspected and 
turbidity was measured using a spectrophotometer. 
 
 
2.4 Characterization of nanoemulsion 
Droplet size and polydispersity index (PDI) of NE was measured by a zetasizer NanoZs 
(Malvern instruments, UK). NEs were diluted 1:10 with deionised water prior of the experiment 
to do away with the effect of viscosity caused on account of emulsion ingredients and also to 
trim down multiple scattering effect. Particle size and PDI measurements were performed at a 
scattering angle of 90◦and at a temperature of 25°C. 
NEs droplet morphology was visualized by Transmission Electron Microscopy (TEM) 
Sample for TEM analysis was prepared by placing one drop of NEs onto a copper grid. After 
approximately 1 hour images were captured by a transmission electron microscope. TEM 
analysis was performed with a FEI Tecnai G12 (LAB6 source) equipped with a FEI Eagle 4 K 
CCD camera (Eindhoven, The Netherlands) operating with an acceleration voltage of 120 kV. 
Turbidity of the formulated NEs was evaluated on a UV/VIS spectrophotometer (UV 
1800, Shimadzu, Japan) at 502 nm fitted out with a 1 cm quartz cell (Hellma, Germany). The 
turbidity was calculated as turbidity × path length = 2.303 × absorbance {Fletcher, 1995 35 /id}. 
The pH of each formulations were evaluate using a crison basic 20 pHmeter equipped 
with an elecrode 50 10T (crison, Spain). 
 
2.5 Stability studies 
2.5.1 Centrifugation study 
The formulated NEs were studied for their resistance to centrifugation. All the 
formulations were subjected to centrifugation (mikro 20, Hettich, Germany) at 13,000 rpm for 
30 min and observed for phase separation, creaming and cracking (if any). 
 
2.5.2 Heating–cooling cycle 
This study was performed to check the effect of temperature variations on the stability of 
NEs formulations. Samples were stored between 4 and 40 °C for a period of 48 h at each 
temperature. The heating–cooling cycle was repeated four times. The NEs formulations that did 
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not show any instability such as cracking, creaming and phase separation were chosen and 
subjected to freeze–thaw stress. 
 
2.5.3 Freeze–thaw cycle 
In this study, NEs formulations were subjected to freeze–thaw stress between −21 and 
+25°C, with storage at each temperature for a minimum period of 48 h. Three freeze–thaw 
cycles were performed and the formulations that resulted to be stable to this stress were further 
characterized and preferred for application study. 
 
2.5.4 Kinetic stability 
NEs formulations were preserved at room temperature for checking out the intrinsic 
stability. The emulsion formulations were observed for phase separation, creaming and cracking 
with respect to prolonged storage time period. Kinetic stability was investigated by measuring 
droplet size of the NEs at different intervals of time. 
 
2.5.5 Dilution test 
The dilutability of the NEs studied was assessed to know whether these systems could be 
diluted with the external phase of the system without phase separation. In an effort to imitate the 
dilution process that occur when the NEs loaded hydrogel were prepared, the selected NEs were 
diluted with water in proportions of 1:1 and 1:10. Dilution was performed with vigorous 
vortexing for 5 min at ambient temperature and assessed visually for transparency and size for a 
period of at least 48 h. Diluted systems were considered as NEs if they maintained their physical 
integrity. 
 
 
2.6 Hydrogels preparation and characterization 
Hydrogels were obtained by spraying-deposition method using a pharmaceutical grade 
spray pump. The selected pump is calibrated to dispense exactly 140 L of an Alg solution at 
1% w/v in each actuation. The spraying-deposition procedure was standardized as follows: a 1% 
(w/v) Alg water solution was sprayed twice on a lightly wet glass petri dish (36 mm diameter), 
followed by a single spray of a 2% w/v CaCl2 aqueous gelling solution. A thin layer of hydrogel 
formed immediately. Three layers were deposited one above the others for each preparation. 
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The hydrogels containing NeTTO were prepared by pre-dispersing 20 mL of NEs in 100 mL of 
Alg solution under magnetic stirring. 
Hydrogel homogeneity was determined by the dry to wet weight ratio method.
282,283
 
Hydrogels were cut in four slices (labeled A-D as shown in Figure 39) and weighed on 
analytical balance. The specimen were dried to constant weight (60° C for 24h under vacuum) 
and weighed again. The calculated dry to wet weight ratio provides an indication of gel 
homogeneity. The reported data are the average of three samples ± standard deviations. 
 
Figure 39. Schematic representation of hydrogels division for homogeneity evaluation.  
 
Water content was determined gravimetrically on hydrogels as obtained by spray 
deposition. The initial weight of each sample was recorded using an analytical balance. 
Successively, the hydrogels were frozen overnight at −40◦C, and then lyophilized at 0.01 atm 
and -60°C in a Modulyo apparatus (Edwards, UK). After lyophilization the samples were 
reweighed and the water content (WC%) was calculated using the equation: 
 
      
    
  
       
where W is the mass of the freeze dried sample and W0 is the mass of the initial wet 
sample. The weight loss, expressed as %, corresponds to water content.  
Degradation of hydrogels containing NEs was followed through an modified Enslin 
apparatus (see chapter II) designed for mimic the wound bed. Hydrogels were placed on a 
porous glass filter and maintained in constant contact with an hydration medium to simulate 
biological fluids in tissue injuries. As simulated fluid we employing Phosphate Buffer Saline 
(PBS, NaCl 120 mM, KCl 2.7 mM, Na2HPO4 10 mM) at pH 7.4, lactate solution at pH 4.8, or a 
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saline solution. Three replicates were performed for each sample and photos were taken 
occasionally during the experiment. 
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3 Results and discussion 
3.1 Phase diagrams 
Polysorbate 80 is a nonionic surfactant (HLB=15) giving NEs without the aid of a co-
surfactant but over only a very limited range of concentrations. In preliminary experiments we 
found that the maximum amount of TTO that could be incorporated in the NEs was 10% (w/w) 
with a total surfactant content of 80–85% (w/w) (Data not shown). The use of a non-ionic 
surfactant, as the Polysorbate 80, alone makes difficult the spontaneous formation of the zero 
mean curvature lipid layers, necessary for NEs formation. For this reason to achieve the ultra-
low interfacial tensions necessary for the formation of the small droplets an high amounts of 
surfactant is required. To extend NEs area, a co-surfactant such as a short chain alcohol has 
been traditionally employed because alcohols are able to increase the hydrophilic–lipophilic 
balance of Polysorbate 80 by decreasing the hydrophilicity of the polar solvent (external 
aqueous phase).
284
 The presence of a short chain co-surfactant allows the interfacial film 
sufficient flexibility to adopt the different curvatures required to form NEs.  
A pseudo-ternary phase diagram, that describes the experimental conditions in which the 
components must be combined to form clear preparations is of relevance to characterize NE 
systems. Pseudo-ternary phase diagrams composed of polysorbate 80 (S), ethanol (used as co-
surfactant, CoS), TTO (termed the oily phase) and water (W) were constructed at room 
temperature to show the relationship between composition and phase behavior of the samples 
(Figure 40). The construction of phase diagrams makes easy to find the concentration and ratio 
of the components allowing the existence of a range of NEs.  
. 
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Figure 40. Phase diagrams obtained at different S:CoS volume ratios. W = water phase, O= oil phase, 
S/CoS = Surfactant/co-surfactant 
 
 
For the selected components, the shaded areas of the pseudo-ternary diagrams in Figure 2 show 
the regions allowing stable (and transparent) NEs formation. In all the cases, the areas of stable 
NE formation extended over a more or less limited area in the S/CoS-rich part of the phase 
diagram. Using different S/CoS ratio gave a smaller zone of stable NE formation caused by the 
effect of ethanol on interface fluidity and consequently hydrophilic–lipophilic balance (HLB). 
The HLB describes the simultaneous attraction of the surfactant mixture for the oil and aqueous 
phases, so when it is similar to the required HLB of the NE oil phase, the system provides the 
minimum energy condition for NE formation. The polysorbate 80/ethanol 1:1 (v/v) ratio was 
used to produce stable NEs in order to obtain the largest NE formation area. In this particular 
region four formulations were selected in order to obtain oil-in-water systems. The remaining 
region of the phase diagram allows to form conventional emulsions.. 
 The red dots shown in figure 2 represent the specific composition of the formulations 
giving different TTO concentrations. The data of the pseudo-ternary phase diagram shows that it 
is possible to add a large volume of aqueous phase and a limited volume of the oily phase 
maintaining the thermodynamic stability of the O/W systems. 
 
 
3.2 Characterization and stability of NEs 
Based on the phase diagrams, four NEs were selected for further investigation. This 
formulation differed in the amount of oil included in the internal phase (Table 1).  
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Light scattering is a routine technique to determine the diameter of the internal phase of 
NEs. The light scattering measures were made for liquid NEs, which were diluted with aqueous 
buffer in order to avoid experimental errors due to short interparticle space between globules.
285
 
The mean diameters and the PDI of selected NEs are shown in table 1. 
 
Table 9. characteristic of the spray deposited hydrogels 
Formulation 
W/S-CoS 
composition (%) 
TTO 
(%) 
Diameter 
(nm ± D.S.) 
Polydispersity 
index 
Turbidity 
(%) 
pH 
NeTTO20 30/50 20 21.95 ± 0.20 0.232±0.012 1.74 5.6 0.1 
NeTTO15 35/50 15 18.31 ± 0.67 0.209±0.038 3.39 5.70.1 
NeTTO10 40/50 10 14.06 ± 0.33 0.206±0.060 2.82 5.80.1 
NeTTO5 45/50 5 11.92± 0.04 0.211±0.054 3.56 5.90.1 
 
 
TTO-loaded NEs showed a very small particle size and narrow size distribution, as 
determined by light scattering analysis. The final TTO concentration influenced the average size 
which increased as TTO amount increased. Low polydispersity (~0.2) was indicative of 
homogeneous monodispersed particles. Morphology of NEs was visualized by TEM (figure 41). 
Emulsion droplets were spherical in shape and the droplet size was confirmed in nanometric 
range. 
 
 
 
Figure 41. Droplet size of NeTTO20. 
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The pH value for all formulations are within the physiological range. 
NEs are thermodynamically stable by definition but even so accelerated testing methods 
are required for evaluation of long term stability. Thermodynamic stability of NEs formulations 
prepared with different oil concentrations were investigated by visual inspection and size 
determination after centrifugation, freeze–thaw and heating–cooling cycles. The centrifugation 
test allowed the evaluation of the absence of phase separation after mechanical stress. After 
centrifugation all NEs were found to be stable, as no change in any of their properties was 
observed. Another mean to test the NEs stability is to subject them to rapid temperature 
changes. All the systems underwent freeze–thaw and heating–cooling cycles, remained stable 
since no significant changes in droplet size were observed after the thermal treatments (data not 
shown). Kinetic stability of NEs was studied by storing the formulation for a prolonged period 
time at room temperature. After 3 months the size remains constant and no sign of phase 
separation was found (figure 42). 
 
 
Figure 42. Kinetc stability of tea tree oil nanoemulsion. 
 
 NE stability to dilution was assessed to verify their capacity to be dispersed in the Alg 
solution employed to produce hydrogels. The dilution test performed in water showed that all 
the NEs studied in this work remained stable for at least 2 days at room temperature after being 
diluted, because no physical changes apparently occurred during this period of time.  
 
 
3.3 Hydrogels preparation and characterization 
Hydrogels were obtained by alternate spraying of Alg and CaCl2 solutions. The spray 
deposition technique allows to realize thin coatings as well as thick hydrogels by cumulative 
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spray. Hydrogels are transparent (Figure 43), with an irregular top surface but a quite regular 
thickness and diameter (Table 9).  
 
  
 
Figure 43. Left: Alg hydrogel, Right: Alg/NeTTO20 hydrogel. 
 
 
The spray procedure to obtain Alg in situ forming hydrogels was standardized as a 
function of two parameters: Alg and CaCl2 solution concentration and number of relative 
Alg/CaCl2 sprays. Alg concentrations higher than 1% w/v were e not suitable for the spray 
deposition technique, due to their high viscosity. Different CaCl2 concentrations were tested (1, 
2, 4, 6, 8%), being 2% the most suitable to give adequate gelation time and homogeneous gels. 
As a matter of fact, 1% CaCl2 was not enough to give a solid gel, while at concentration > 2% a 
too fast gelation occurs causing surface shrinking. Excessively rapid gelation causes the 
formation of an irregular surface upon which successive spray layers give rise to a stratified, not 
homogeneous final gel. The optimal conditions were set as follows: two sprays of 1% Alg 
followed by one spray of 2% CaCl2. Thicker and homogeneous gels were obtained by 
cumulative spray. The number of consecutive layers was set to three in the following. The gels 
were let to complete gelation for 30 min before further characterization.  
Weight, thickness and diameter of freshly-prepared hydrogels are reported table 10. The 
values are averaged on five specimens and averages and standard deviations are reported. 
 
Table 10. Properties of Alg and Alg/NeTTO20 hydrogels. 
Hydrogel Weight (g) Thickness (mm) Diameter (cm) 
Water content 
(%) 
Alg 1.250 ± 0.025 1.41 ± 0.43 2.53 ± 0.05 72.56 ± 2.35 
Alg/NeTTO20 1.154 ± 0.05 0.96 ± 0.12 2.73 ± 0.06 61.14 ±1.29 
107 
 
 
Structural uniformity of spray hydrogels is crucial for biomedical applications not only 
from a drug delivery viewpoint to achieve uniform distribution of the drug in the matrix, but 
especially to get good material properties. The homogeneity of Alg and Alg/NeTTO20 
hydrogels was estimated by the dry/wet weight ratio method. A constant weight ratio across the 
constituent slices is indicative of homogeneous gel. Homogeneity profiles of gels showed no 
relevant variations between the slices (figure 44), indicating that the spraying-deposition 
process here described can be applied to produce homogeneous Alg hydrogels suitable for 
wound dressing. Moreover, the presence of NEs did not significantly affect gel homogeneity in 
the concentration range studied 
 
  
Figure 44. Dry/wet weight ratios of Alg and Alg/NeTTO20 hydrogel slices.  
 
Mean water content, determined on five different preparations of Alg and Alg/NETTO20 
hydrogels are reported in Table 2. The decrease of water content in NE-loaded hydrogel is 
consistent with the reduced water content of the initial Alg solution. 
In order to ensure a prolonged and durable protection of the wounds, hydrogels are 
expected to be stable when in contact with the wound bed for a reasonable time. Degradation 
has been qualitatively assessed by simulating the wound bed through the experimental system 
described in section 2.6.3. As the exudate pH in chronic wounds is reported to fall in the 4,8 - 
9,8 pH range,
286
 solutions with different pH, namely 4,8 and 7,2, were tested. Nevertheless, no 
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differences were appreciated. Hydrogels swelled in the first 24 h while becoming thinner after 
48 h, indicating that some degradation occurred due to exchange of Ca
2+
 ions with those present 
in the medium. 
 
3.4  Alg/NeTTO composite hydrogels 
Alg has been extensively studied as wound dressing material, but as a hydrophilic 
polymer, it hardly incorporates as such lipophilic liquids such as TTO. Using an o/w NEs we 
can uniformly disperse TTO into Alg hydrogels and increase its dispersability. The 
methodology of incorporating NEs droplets in an Alg hydrogel was already investigated by 
Josef et al.
287
 who verified the existence of intact NEs droplets in a crosslinked Alg matrix. 
To obtain Alg/NeTTO composite hydrogels different amounts of NEs were dispersed in 
the Alg solution and then cross-linked the solution by spray deposition. Mixing NE with Alg 
resulted in a clear solution, with no observable phase separation. The addition of a polymer to a 
NEs system can change its structure, and possibly break the spherical droplets. To verify the 
presence of intact NEs, their size inside the Alg solution was checked and, as shown in figure 
45, only a slight difference in size was detected (the mean size changes from 20 to 26 nm). This 
data are in agreement with those reported by Josef et al.
288
 and suggest that the structure of the 
NEs is unchanged upon mixing with Alg. 
 
 
 
Figure 45. NEs size inside the Alg solution. Red line:  NeTTO20; Green line: Alg/NeTTO20 
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4 Conclusions 
Tea tree oil is an natural compound with well recognized wound healing properties and 
for this already used in topical treatments. The methodology of incorporating nanoemulsion 
droplets into alginate hydrogels is already used to create composite hydrogels and could be 
applied to improve the TTO solubility and activities. Stable, NEs was formulated using tea tree 
oil, Tween 80 and water with a very low droplet diameter, directly dependent from the oil ratio. 
Selected NEs formulations were dispersed in alginate solution and cross-linked to obtain solid 
hydrogels. The spray deposition technique used to have in situ forming hydrogel allow as to 
have an homogenous composite system with good phisical properties and no phase separation. 
The existence of intact MEs droplets in the gel was verified and no morphologic change due to 
NEs dispersion were detected. This finding confirmed that the inclusion of TTO in composite 
hydrogels hold great potential in spray deposited hydrogel for wound management 
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MELT-SPUN BIOACTIVE SUTURES CONTAINING 
NANOHYBRIDS FOR LOCAL DELIVERY OF 
ANTINFLAMMATORY DRUGS 
 
 
 Introduction 
Sutures are biomedical devices of natural or synthetic origin used to held together tissues 
that have been separated due to surgery or traumatic injury. Despite the presence of different 
devices for wound closure (staples, tapes and glues) available on the market, sutures are the 
most widely diffused in the medical practice and have a market of around 1.3 billion dollars a 
year.
289
 A suture should fulfil a number of requirements and, unfortunately, no ideal product is 
available and the surgeon generally operates a selection on the basis of availability and 
familiarity.
290,291
 Nevertheless, an appropriate suture should take into account aspects such as 
mechanical properties, resorption rate, risk of infection, and inflammatory reactions that may 
occur during wound healing process. Over the years, new surgical suture materials have been 
developed to better respond to particular surgical needs. Recently, the research has switched 
toward a novel concept of medicated suture that includes a bioactive compound which can be 
released in a defined time frame and help tissue repair.  
Research in this area, although being very attractive, has leaded to very few products 
successfully entering the market.
292,293,294
 The first commercial antimicrobial suture, a 
Polyglactin 910 suture loaded with triclosan, a broad-spectrum antibacterial agent, (Vicryl 
Plus
®
) was approved for clinical uses by the US Food and Drug Administration (US FDA) since 
2002.
295
 The basic concept in these sutures consist in coating a preformed polymeric filament 
with a second biodegradable polymer layer embedding triclosan with the aim to create a zone of 
inhibition to the spread of bacteria and to exert a preventive action against the possible infection 
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of the surgical site.
296
 Nowadays antimicrobial suture are successfully used in a number of 
surgical procedures
297,298,299,300,301,302
 with a reduction of wound site infection and consequent 
cost saving.
303
 For all this reasons this treatment strategy was found to be very promising and 
sutures coated with other drugs such as antithrombotic, analgesics, antineoplastic and 
antiproliferative agents are under investigation.
304
 
Recently Lee et al.
305
 have proposed a new method to obtain medicated suture where a 
commercial suture is covered with a polymeric sheet loaded with a pain relief drug. These 
sutures have been proven to have suitable mechanical properties and a drug release only for 6 
days. Nevertheless, control of drug release rate is a critical factor to design a bioactive suture in 
view of an optimized biological effect. For this reason, more suitable strategies are needed to 
attain both efficient control over drug release rate and adequate mechanical properties. As an 
alternative to coated fibers, electrospun aligned fibers have been developed where different 
active agents are dispersed in a polymer to give a matrix-like structure.
306
,
307
 Unfortunately, 
fibers show weak mechanical properties and electrospinning is difficult to scale-up, making 
these systems difficult to be applied. 
At this regard, a promising alternative is represented by melt-spinning technology. In this 
case, a polymer melt is forced through a spinneret capillary to obtain fibers with properties 
strongly related to the applied drawing extent. The application of this process, even if scalable 
up to industrial level, is limited in the biomedical field where the usual thermolability of 
bioactive additives as drugs and/or the relatively poor elongational properties of biocompatible 
polymer melts, furtherly worsened by incorporation of additives, may prevent a satisfactory 
drawing of fibers compromising their ultimate mechanical properties. 
Among the strategies useful to control drug release from a polymer matrix, the inclusion 
of lamellar structures opens new opportunities to develop smart systems. Recently, magnesium 
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and aluminium hydroxycarbonates referred to as hydrotalcite-like compounds (HT) intercalating 
bioactive molecules have been proposed.
308,309,310,311
 These systems consist of a layer of 
inorganic clays which, under specific conditions, self-organize to form a bilayer. HTs have 
already been proven to be biocompatible and some of them are already used in clinical practice 
as antiacids because of their antipepsin activity.
312
 In specific conditions, HT can intercalate 
different anions or biologically active molecules such as anionic non-steroidal anti-
inflammatory drugs (NSAID),
313
 antibiotics,
314
 up to around 50% by weight and form 
nanohybrids. Depending on drug features (solubility, molecular weight, affinity to HT), fast 
dissolution or sustained release of the drug can be accomplished as a consequence of a de-
intercalation process.
315,316
 Furthermore, a body of interest is growing on the development of 
novel composite systems based on inorganic layered materials and organic polymers. Recent 
studies report on the possibility to introduce organically-modified HT in different polymers as 
fillers opening a new way to integration of bioactive HT in polymeric films, membranes or 
fibers with different potential applications in industrial and biomedical field.
317
,
318
,
319
 In this 
context, on the basis of an European patent owned by some participants to this research,
320
 
Sammartino et al.
321
 incorporated nanohybrids containing the NSAID Diclofenac (DIC) into 
poly(-caprolactone) (PCL) films and demonstrated effective control of drug release as 
compared to free drug directly dispersed into the polymer. 
Prompted by these considerations, in this paper we offer a proof of principle on the 
possibility to obtain a sustained-release biodegradable suture through the incorporation of a 
drug-HT nanohybrid in a thermoplastic polymer. To this purpose DIC-intercalated HT was 
incorporated in a fiber of poly(-caprolactone) (figure 1). The fiber was produced by melt 
spinning and characterized in terms of morphology, size, mechanical properties, drug release 
and in vivo performance. 
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Figure 46. Graphical representation of loaded monofilament. 
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 Materials and methods 
2.1. Materials 
A nanohybrid containing synthetic hydrotalcite and Diclofenac (HT-Dic, 
[Mg2Al(OH)6](C14H10Cl2NO2) * 2H2O, Mg/Al Ratio 1.8, distance between layers = 23.6 Å, 
moisture 7.0 %, Diclofenac loading =59.6 %) was obtained from Prolabin & Tefarm (Italy). 
Diclofenac sodium (Dic) was purchased from Farmalabor (Italy). Poly(ε-caprolactone), PCL, 
used for this study (CAPA
®
 6800) was from Perstorp corporation (UK). HPLC-grade 
tetrahydrofuran (THF), acetonitrile and methanol, analysis-grade acetone and dichloromethane 
were from Carlo Erba (Italy). Synthetic hydrotalcite (HT, Mg6Al2(CO3)(OH16) * 4H2O), sodium 
chloride, potassium chloride, HPLC-grade trifluoroacetic acid (TFA), sodium phosphate dibasic 
and Potassium phosphate monobasic (HPLC grade) were obtained from Sigma-Aldrich (USA). 
Distilled filtered (0.22 m) water was employed. 
 
2.2. Fiber production 
Fibers were prepared through extrusion, drawing and subsequent cold drawing to the final 
diameter of approximately 300 m. Prior to the extrusion process, the components were 
separately sieved to obtain a fine powder (97 % of the powder passed through a #140 sieve with 
a mesh size of 106 m according to Ph. Eur. 7th edition). The mean diameter and size 
distribution of powders was determined by laser light scattering (Coulter LS 100Q, USA). 
Particle size is expressed as volume mean diameter (m) ± SD of values collected from three 
different batches. For Zeta potential measurements, HT-Dic was dispersed in water and 
analyzed on a Zetasizer Nano Z (Malvern Instruments, UK). 
The base materials were mixed in a HAAKE twin screw extruder using a screw speed of 
20 rpm and applying a temperature profile going from 60 °C, at feed zone, to 100 °C at the die. 
The filament was cooled in stagnant air (at 23°C) and collected with a take-up speed of 4 
m/min. The as-spun fibers (with a diameter of about 900 m) were drawn, using a (DSM Xplore 
Conditioning Unit) with a temperature of 50°C, to the final diameter of about 300 m 
(corresponding to a draw ratio of 9). 
Different compositions of the fibers, reported in Table 1, were selected in order to 
investigate the effect of Dic intercalated in HT (Dic/HT) as compared to free Dic (PCL/HT-Dic 
vs. PCL/Dic); ii) the influence of HT in systems containing free Dic (PCL/HT/Dic vs. PCL/Dic) 
and iii) the possible effect of free Dic in fibers involving intercalated Dic (PCL/HT-Dic vs. 
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PCL/HT-Dic/Dic). We fixed Dic loadings in the fiber at 9 and 18% by wt in order to test the 
system at high loading where control of drug release is generally poor.  
 
2.3. Mechanical properties 
Tensile properties of straight and simple knotted (according to Ph. Eur. 7
th
 edition) fibers 
were measured using a universal testing machine (Alpha Technologies mod. 2020) equipped 
with a 10 N load cell. All tensile experiments were carried out at a strain rate of 300 mm/min, 
using a gage length of 150 mm, at 23°C. For each sample, at least five specimens were analyzed 
(if the fiber broke in a clamp or within 1 cm, the result was discarded and the test was repeated) 
and average results are reported with their standard deviation. The mean diameter was obtained 
after three measurements at points evenly spaced along the suture using a 0.001 mm accuracy 
digital micrometer. Mechanical properties of fibers are expressed in terms of elastic modulus, 
breaking load, breaking stress and percent elongation at break.  
 
2.4. Scanning electron microscopy/Energy Dispersive X-Ray 
Microanalysis 
Sutures shape and morphology were analyzed by scanning electron microscopy (SEM) 
(Quanta 200 FEG; FEI, USA). To analyze internal structure of fiber wire sections were 
prepared. The sample was included into Tissue Tek
®
 OCT (Sakura, Japan) and then cut into 40 
µm slice using a Tissue-Tek
®
 Cryo3
®
 Microtome/Cryostat (Sakura, Japan). The samples were 
stuck on a metal stub and coated with gold under vacuum evaporator for 90–120 s. Surface 
composition of the samples was investigated by Energy Dispersive X-ray spectroscopy (EDS) 
microanalysis through a X-EDS detector (Oxford Inca Energy System 250 equipped with 
INCAx-act LN2-free detector) . 
 
2.5. HPLC analysis of Diclofenac sodium  
Dic analysis was carried out by RP-HPLC on a system consisting of a FCV-10ALvp 
mixer, a LC-10ADvp pump equipped with a SIL-10ADvp autoinjector, a SPD-10Avp UV–vis 
detector and a C-R6 integrator from Shimadzu (Japan). The analysis was performed on a Luna 
5μ C18 (250   4.6 mm) (Phenomenex, USA) at a flow rate of 1.0 mL/min. The injection 
volume was 20 µL in all the experiments and the detection wavelength fixed at 238 nm. 
For Dic quantitative analysis the mobile phase was a acetonitrile/acid water both 
modified with 0.1% TFA mixture in the ratio 70:30 v/v. A Dic standard solution in water was 
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prepared and stored at 4° C until use. Calibration curve was constructed by injecting solutions 
with concentrations in the range 0.3—30 μg/mL LOD was 0.08 μg/mL whereas QOD was 0.26 
μg/mL. 
 
2.6. In vitro release studies 
In vitro release of Dic from the HT-Dic nanohybrid was evaluated by dispersing 2 mg of 
HT-Dic in 5 mL of release medium at 37°C. Three different release media were prepared: 
NaCl/KCl solution (NaCl 120 mM, KCl 2.7 mM), Phosphate Buffer Saline (PBS, NaCl 120 
mM, KCl 2.7 mM, Na2HPO4 10 mM) and Phosphate Buffer Saline at double chloride 
concentrations (PBS2, NaCl 240 mM, KCl 5.4 mM, Na2HPO4 10 mM) both at pH 7,4. At 
predetermined time intervals 1 mL of supernatant was collected after centrifugation (5000 rpm 
15 min 4°C) and analyzed by the analytical method previously described for Dic quantification. 
The in vitro release of Dic was evaluated by immersing three fiber portion (3 cm) taken 
from different part of extruded suture in 5 mL of Phosphate Buffer Saline (PBS, NaCl 120 mM, 
KCl 2.7 mM e Na2HPO4 10 mM) at pH 7,4 and 37°C under gentle shaking. Periodically 1 mL 
of release medium was collected and replaced with the same volume of fresh medium. The 
samples were analyzed by the analytical methods previously described and results are reported 
in terms of released Dic percent. 
Fiber morphology was evaluated also at the end of the release experiment. To this 
purpose, fiber was washed with water three times, freeze-dried and then analyzed by SEM.  
 
2.7. In vivo experiments 
Male CD1 mice (30-35 g) (Harlan, Italy) were purchased from Harlan Italy (San Pietro al 
Natisone, UD, Italy) and housed in stainless steel cages in a room kept at 22 ±1 °C with a 12:12 
h light/dark cycle. The animals were acclimated to their environment for 1 week and had ad 
libitum access to standard rodent chow pellets. All procedures met the guidelines of the Italian 
Ministry of Health (D.L. no.116 of January 27, 1992) and guidelines in the European 
Communities Council (Directive of November 24, 1986, 86/609/ECC). 
Mice were anesthetized with ketamine (100 mg/kg) and xylazine (10 mg/kg), the back 
was shaved and scrubbed with betadine, and an incision (4 cm in length, and 0.2 cm in deep) 
was made in the middle using a number 12 blade. Five different sutures were used: 1) PCL 
suture; 2) PCL/HT/Dic, 3) PCL/Dic; 4) PCL/HT-Dic/Dic; 5) PCL/HT-Dic. The wounds were 
closed with three sutures for sub-cutaneous and four sutures for cutaneous tissues. After 3 days 
from surgery, mice were killed and cutaneous and sub-cutaneous tissues were removed. The 
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samples were fixed in 10% neutral buffered formalin, then processed and embedded in paraffin, 
according to standardized protocol. Sections of 4 micron were stained with hematoxylin and 
eosin. 
Two histological parameters were evaluated in each sample: inflammatory infiltrate and 
granulation tissue. They were graded according to semi quantitative score as:  
+ = weak  inflammatory infiltrate/  low amount of granulation tissue  
++ = moderate inflammatory infiltrate/ moderate amount of granulation tissue 
+++ = intense inflammatory infiltrate / intense amount of granulation tissue 
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 Results and discussion 
3.1. Fiber extrusion and morphology 
The aim of this work was to obtain a drug-eluting synthetic suture with antiinflammatory 
activity and to test its effects in vivo. Fine tuning of drug delivery rate was considered as a key 
parameter to achieve regional prolonged release and to promote healing process. We focused on 
melt-spinning technique to produce polymeric fibers with regular circular cross section since it 
couples good versatility, fast industrial scale up and does not require organic solvents. Melt-
spinning perfectly fits loading of very hydrophilic drugs in water-insoluble polymers such as 
PCL ensuring high entrapment efficiency. After characterization, the HT-Dic nanohybrid was 
included in PCL fibers, which were then drawn to obtain suitable diameter and fully 
investigated. 
Properties of HT-Dic nanohybrid are reported in Figure 2. The size distribution curve 
showed a monomodal trend and a HT-Dic mean particle diameter of 2.4 ± 0.2 μm. Surface 
charge of the nanohybrid was slightly negative. SEM analysis confirmed the size and the HT 
lamellar structure. The release profile of Dic from the HT-Dic nanohybrid was evaluated in 
physiologically-simulated conditions. HT consists of layers of magnesium hydroxide, with 
aluminium isomorphically substituted to give a net positive charge inside the layers. This charge 
is balanced by interlayer hydrated anions, resulting in a multilayer of alternating host layers and 
gallery ions.
322
 To achieve drug release, the presence of an anion capable of exchange with that 
located inside the nanohybrid is needed. Since in a physiological environment the most 
available anions are chlorines and phosphates, Dic release from HT-Dic was tested in media at 
different chloride and phosphate concentration (Figure 47c). As expected for this type of 
system, release rate was strongly influenced by the ionic composition of the medium. PBS 
ensured a complete release of Dic from the intercalation product and was selected for further 
release experiments on fibers. 
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Figure 47. Properties of HT-Dic. a) size distribution; b) SEM micrograph; c) release profile of Dic in 
PBS (NaCl 120 mM, KCl 2.7 mM, Na2HPO4 10 mM), PBS2 (NaCl 240 mM, KCl 5.4 mM, Na2HPO4 
10 mM) and NaCl/KCl (NaCl 120 mM, KCl 2.7 mM) solution at pH 7.4 and 37 °C. Results are reported 
as mean ± SD of three measurements. 
 
 
Biodegradable PCL fibers with different compositions were processed by a two-step 
melt-spinning method (melt extrusion and hot draw) (Table 11). Melt spinning has proven to be 
a robust method for the production of several biomedical devices and it has been found to be 
useful in the pharmaceutical industry as well.
323
 Since many years this technique has been 
already used for the industrial production of sutures because it is an economical process with 
reduced production time, few processing steps, and offering the possibilities to work in 
continuous. Furthermore, the capacity of melt extrusion to disperse in a matrix different active 
pharmaceutical ingredients at molecular level (forming solid solutions) has been seen as a 
possible strategy to increase solubility and bioavailability of water-insoluble compounds.
324,325
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One of the disadvantages of this production method is the necessity to operate at high 
temperature in order to melt the polymer while most drugs may degrade at high temperature. In 
the present case, RP-HPLC qualitative analysis of Dic extracted from fiber after extrusion 
confirms that the production method does not affect drug stability. Nevertheless, this loading 
strategy can be of benefit for drugs poorly stable upon heating as well as drugs undergoing 
polymorphism in order to maintain their chemical-physical integrity. 
 
 
Table 11. Composition of monofilaments. 
Fiber PCL (%) HT-Dic (%) HT (%) Dic (%) 
Dic 
(mg/cm) 
Diameter 
(µm) 
PCL/HT-Dic 82 18 - - 0.14 315±30 
PCL/Dic 82 - - 18 0.17 324±21 
PCL/HT-Dic/Dic 75 17  8 0.22 328±67 
PCL/HT/Dic 75 - 8 17 0.12 264±44 
 
 
After extrusion, fibers were analysed by scanning electron microscopy (SEM) to evaluate 
size and surface morphology (Figure 3). In details, as spun fiber of PCL formed at 100°C die 
temperature showed extruding lines on the surface (Figure 3a), likely due to polymer curing in 
the applied processing conditions. Nevertheless, the presence of some particles on the surface of 
the fibers containing HT or HT-Dic was observed. To investigate the nature of these particles, 
fiber surface was analysed by Energy Dispersive X-ray spectroscopy (EDS). Particles were 
composed mainly by magnesium and aluminium, thereby suggesting that HT-Dic particles 
locate also on the filament surface during processing (Figure 3b).  
 
a 
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Figure 48. SEM images of monofilament surface (a) and EDS analysis of PCL/HT-Dic monofilament 
surface (b). The sample is representative of outer monofilament portion. 
 
 
To evaluate the inner morphology of the fibers, SEM images on fiber sections were taken 
(Figure 49). All the fibers had round cross-sectional geometry and non-porous morphology, 
with an average diameter around 0.3 mm comparable with those measured by a calibre (table 
11). Micrographs indicated a rather homogeneous dispersion of included components with the 
presence of small internal voids due to a decrease of feeding load during extrusion. 
 
 Mean (%) Standard Deviation 
C 66.74 0.20 
O 26.16 0.18 
Mg 2.06 0.21 
Al 1.21 0.07 
Cl 3.83 0.10 
1
 mm 
300 m 
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Figure 49. SEM images of monofilament section. The sample is representative of other inner section. 
 
 
3.2. Mechanical properties 
Given that the use of sutures strongly depends on mechanical properties, their strength is 
the most frequently reported parameter.
326
 There should be a proper match between suture 
strength and tissue strength 
327
 and for this reason the selection of proper suture depends also 
from the tissue involved. Furthermore, tensile properties of sutures are important when making 
a knot. If the material is too weak and the knotting force is stronger than tensile strength of 
suture material, suture can easily break while tightening the knot.
328,329
 
Results of tensile tests performed on melt-spun straight and knotted filaments are shown 
in Figure 50 and Figure 51.  
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Figure 50. Elastic modulus of monofilaments with different composition. Results are the mean of five 
measurements, error bars are standard deviations. 
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Figure 51. Mechanical properties of straight and knotted monofilaments: breaking load (a); breaking 
stress (b); elongation at break (c). Results are the mean of five measurements, error bars are standard 
deviations 
 
The elastic modulus data (Figure 51) indicated that the inclusion of particulate 
components decreased the stiffness of the fiber with respect to pure PCL. In particular, the 
addition of HT-Dic caused a reduction of tensile modulus from 1400 MPa to about 1100 MPa (-
25%) while the inclusion of Dic caused a reduction of the modulus up to about 480 MPa 
(corresponding to -66%). Systems including both Dic and HT as well as Dic and HT-Dic also 
showed a significant decrease in modulus. Tensile properties (breaking stress and elongationa at 
break) of straight and knotted fibers are shown in Figure 51. Data indicated that, whitin 
esperimental errors: 
- the knotted fibers had the same breaking stress and the same elongation at break of 
straight fibers thus indicating that the knot does not represent a weakness to the fiber; 
- composite fibers showed a three-fold decrease with respect to pure PCL fibers in 
breaking stress; 
- fibers containing HT-Dic showed fragile behaviour with elongations at break around 
20% (other systems being around 70%) and a tenacity in the range 10÷17 MJ/m
3
 (other systems 
being around 70 MJ/m
3
). 
The effect of knotting on the strength of various sutures was studied by Kim et al.,
330
 who 
concluded that the knotting of a suture reduced its tensile strength. In the present case the knots 
do have only a marginal influence on the mechanical behaviour of the fibers, and this is an 
advantage for their use in slow-healing tissue (skin, fascia and tendons). 
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3.3. In vitro release and degradation 
The release profile of Dic from fibers was assessed in PBS at pH 7.4 and 37 °C, 
simulating physiological conditions (Figure 7). In all the samples, an initial burst of Dic release 
was observed. The control fiber containing free HT and Dic (PCL/HT/Dic) completely eluted its 
Dic content in around 14 days, thus showing a poor control over release rate. The fibers 
containing HT-Dic (PCL/HT-Dic) reached around 80% release after 70 days thus providing an 
effective release control. In the fiber containing both HT-Dic and a fraction of free Dic 
(PCL/HT-Dic/Dic) the release rate was slowed down further, giving an amount of released Dic 
around 40% after 60 days. These data suggest that a fine tuning of release profiles can be 
accomplished playing on reciprocal HT-Dic/Dic ratio and optimal rate may be selected 
according to the therapeutic needs. Dic amount released from PCL fiber (PCL/Dic) was 
comparable to that released from PCL/HT-Dic although poorly modulated in the initial stage. 
After 70 days Dic was still released in native form indicating the protective effect of PCL and 
HT on its chemical structure. 
 
 
 
Figure 52. Dic release from monofilaments in PBS (10mM) at pH 7.4 and 37 °C. Results are reported as 
mean ± standard deviation of three measurements. Lines through data points are to guide the eye.  
 
 
In order to evaluate the mode of degradation, fiber morphology was analysed after 70 
days of release in PBS at pH 7.4 at 37 °C (Figure 52). Surface modification of the fiber, likely 
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due to slow polymer progressive degradation, was observed without the occurrence of fractures. 
As expected, the extent of polymer degradation was very limited and confined to the surface, 
confirming that this kind of system behaves mainly as a surface eroding system. Nevertheless, 
surface degradation of PCL determined the outcrop on the surface of HT and HT-Dic as shown 
by EDS analysis. This phenomenon was particularly evident in the fiber PCL/HT/Dic.  
 
 
 
Figure 53. SEM images of monofilaments after 70 days of incubation  in PBS (10 mM) at pH 7,4and 
37°C. 
 
This degradation mode suggests that DIC release from fiber is predominantly controlled 
by drug dissolution and diffusion. In the case of PCL/Dic, drug diffusion in the rubbery PCL 
phase as well as in polymer mesopores is the prevailing mechanism. When the fiber contains 
1 mm 100 µm 10 µm 
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HT-Dic nanohybrid, Dic needs to diffuse out of the lamellar structure and then through the 
polymer matrix, which adds a supplementary process contributing to the overall release. 
Sustained Dic release may represent a clinically relevant therapeutic modality. It is worth 
of note that besides anti-inflammatory effect, sustained Dic release can have an impact also in 
the management of postoperative pain, thus minimizing the dose of medications to lessen side 
effects while still providing adequate analgesia. To date, perioperative administration of a single 
local dose of nonsteroidal anti-inflammatory drugs has shown inconclusive efficacy.
331
 Rather 
than a single bolus, Lavand'homme et al.
332
 found that continuous intrawound infusion of Dic 
demonstrated a greater opioid-sparing effect and better postoperative analgesia than the same 
dose administered as an intermittent intravenous bolus. Thus, Dic-eluting sutures can combine 
delivery concepts to a biomedical device to exert both effective control of inflammatory phase 
and alleviation of post-operative pain. 
  
3.4. In vivo effects 
To assess in vivo anti-inflammatory effect and to relate it to fiber composition, sutures 
were employed to close a traumatic wound in mice. Two histological parameters were evaluated 
in each sample: inflammatory infiltrate and granulation tissue (Table 12).  
 
Table 12. Inflammatory infiltrate and granulation tissue in specimens. 
 
 Inflammatory Infiltrate Granulation Tissue 
Fiber 
CUTANEOUS 
TISSUE 
SUB-CUTANEOUS 
TISSUE 
CUTANEOUS 
TISSUE 
SUB-CUTANEOUS 
TISSUE 
PCL/Dic ++ ++/+++ - - 
PCL +/++ +/++ - - 
PCL/HT-Dic/Dic + ++ - - 
PCL/HT/Dic +/- + - - 
PCL/HT-Dic + ++ - + 
 
+ = weak  inflammatory infiltrate / low amount of granulation tissue 
++ = moderate inflammatory infiltrate / moderate amount of granulation tissue 
+++ = intense inflammatory infiltrate / intense amount of granulation tissue 
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Figure 54. Hematoxylin and eosin-stained sections of sub-cutaneous tissue from mice at suture site (H&E 
20x). a) PCL/Dic; b) PCL; c) PCL/HT/Dic; d) PCL/HT-Dic  
 
 
In samples containing PCL/Dic an inflammatory infiltrate variable from moderate to 
intense was observed, especially at the level of the sub-cutaneous tissue (Figure 9a), without 
formation of granulation tissue. For PCL fiber, the inflammatory response appeared to be less 
intense (Figure 9b), again without the formation of granulation tissue. In all the other specimens 
no variations in the inflammatory response was observed, except for PCL/HT/Dic where this 
reaction was found to be less intense (Figure 9c). It is worth of note that the presence of 
granulation tissue was observed only in the sub-cutaneous tissue of PCL/HT-Dic sample (Figure 
9d). Regardless of the surgical site, in the injured tissue the inflammatory reaction reduces the 
damage, removes damaged tissue components and stimulates the deposition of extracellular 
matrix, inducing angiogenesis. Therefore the observation that a granulation tissue is present can 
be related to an expression of a more effective and early reparative process in progress. 
 
 
a b 
c d 
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 Conclusions 
In summary, we have developed a drug-eluting anti-inflammatory suture that could have 
the dual function of closing the site of wound excision while providing sustained localized 
delivery of Diclofenac. The melt spun fiber, containing HT-Dic, has shown a homogenous 
distribution of fillers, good mechanical properties, tuneable release rate as a function of 
composition and in vivo activity that suggests their use in surgical practice. The strategy 
proposed to produce drug-eluting fibers is of great potential and versatility. Indeed, melt-
spinning is a simple and reproducible process that can be scaled-up at industrial level and is 
adaptable to incorporate a large variety of drugs. On the other hand, control of fiber properties 
by nanohybrid should help to extend the applicability of our concept to other bioactive drugs. 
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